2021 USCHA Program Book 3

VIRTUAL

PROGRAM

December 2-3, 2021 Online • #2021uscha

This ad is not intended to imply that the model pictured has HIV

oUr LIFe’s worK

FIghtIng hIV YesterdaY, todaY, and tomorrow

To end HIV and AIDS once and for all, we must close the gaps in care for people who need it most. That’s why ViiV Healthcare is proud to support USCHA 2021 and our shared goal of addressing health disparities and stigma in every community.

Follow us:

Trademarks are owned by or licensed to the ViiV Healthcare group of companies ©2021 ViiV Healthcare group of companies or its licensor.

VIRTUAL

USCHA CONFERENCE PLANNING TEAM

The 2021 USCHA Conference planning team looks forward to making your participation in USCHA a comfortable and rewarding experience. If you have any questions, do not hesitate to contact the planning team at conferences@nmac.org.

GENERAL INFO 04

Welcome Letter

05 Agenda 06 Sponsors 10

Program Partners & NMAC Staff/Board

CONFERENCE INFO TARA BARNES-DARBY Director of Conferences

Tara is your contact for all conference-related information and has overall responsibility for the conference.

05 Agenda 07

Exhibitor List

THURSDAY 11 Sessions-At-A-Glance 14 Sessions

ALISON J. MCKEITHEN

Assistant Director of Conferences

Alison is your contact for all conference related information, particularly questions about sessions, faculty and special events. Alison is your contact for all things workshop, poster, institutes, masters series and affinity sessions related.

FRIDAY 33 Sessions-At-A-Glance 39 Sessions

SESIONES EN ESPAÑOL 66

Translated Sessions

SHANTA’ GRAY

Senior Registrar and Meeting Planner

Shanta‘ is your contact for conference registration and scholarship concerns.

#2021USCHA

3

TO THE 25TH ANNUAL UNITED STATES CONFERENCE ON HIV/AIDS Here we are again, my friends.

Last year at this time, I was telling you that this wasn’t what we had planned. Well, this REALLY isn’t what we had planned.

If you had told me last year that we’d have to pivot to an online conference again, I would have told you you were crazy. Yet here we are.

I know you are all disappointed that we will go another year without meeting in person for USCHA. And no one is more disappointed than all of us in the NMAC family. But we felt the issue of safety was simply too critical to ignore.

I’ve been very concerned about our loved ones over 50 living with HIV through the whole COVID pandemic. We already knew that they were facing issues with isolation, loneliness, depression, and PTSD. I’m afraid that the enforced isolation of COVID has only exacerbated those issues for them. And I’m worried about what that can ultimately mean for them.

I hope this conference, even though it is virtual, will help to alleviate some of that isolation. We’ve worked very hard to make this conference not just an opportunity for training and eduction, but a chance to connect with others, reinforce those strands in your support net, and hopefully, establish some new connections.

While any attempt to predict the future is pretty much impossible now, we are hoping that this will be the last time we have to meet like this and that 2022 will allow us to return to the in-person meetings that we know and love.

We’ve worked very hard to make this conference not just an opportunity for training and eduction, but a chance to connect with others, reinforce those strands in your support net, and hopefully, establish some new connections.

Until then, I hope that this conference gives you as much hope, joy, knowledge, and connection as we can provide now.

And know that all of us at NMAC are here to help in any way we can.

Enjoy the conference. And I can’t wait to SEE all of you in 2022.

Paul Kawata, Executive Director, NMAC

4

2021

UNITED STATES CONFERENCE ON HIV/AIDS

USCHA AGENDA DEC

THURSDAY

10:00 am 11:00 am

10:00 am 11:00 am

Morning Devotional

2

DECEMBER 2-3, 2021

DEC

FRIDAY Morning Devotional

VIRTUAL

3

10:00 AM

Pre-Conf. Session 10:00 AM-11:00 AM

Session 2 Workshops

11:00 AM

11:00 AM - 12:00 PM

Opening Plenary Session

Gilead Sciences Plenary Session

12:00 PM - 1:15 PM

12:00 PM - 1:00 PM

12:00 PM

Institutes 2:30 PM - 4:00 PM

Session 1 Workshops 4:30 PM - 5:30 PM

Session 3 Workshops 1:15 PM - 2:15 PM

LOUNGES OPEN / 12:00 pm - 5:00 pm

1:15 PM - 1:45 PM

VIRTUAL EXHIBIT HALL / 1:00 pm - 5:00 pm

Poster Presentations LOUNGES OPEN / 12:00 pm - 5:00 pm

VIRTUAL EXHIBIT HALL / 1:15 pm - 5:00 pm

1:00 PM

2:00 PM

Session 4 Workshops 2:30 PM - 3:30 PM 3:00 PM

Institutes

4:00 PM

4:00 PM - 5:30 PM

5:00 PM

ViiV Healthcare Plenary Session 5:45 PM - 6:45 PM

USCHA Presents a Special Screening of FAUCI

Closing Plenary Session 5:45 PM - 6:45 PM

6:00 PM

7:00 PM

7:00 PM - 8:00 PM

#2021USCA

5

A Special Thank You to our Sponsors

who have made significant contributions to the United States Conference on HIV/AIDS.

PRESENTING SPONSOR PRESENTING SPONSOR

PREMIERE SPONSORS

COLLABORATING SPONSOR

THERA

technologies

COLLEAGUE SPONSOR

6

2021

UNITED STATES CONFERENCE ON HIV/AIDS

MEDIA SPONSOR

Accredo Pharmaceuticals

John Snow, Inc.

ACOJA Consulting LLC

Merck

AIDS Education & Training Center National Coordinating Resource Center

Mesmerize

AIDS United AIDSVu Avita Pharmacy Black AIDS Institute CAI Global Capacity Building Assistance Provider Network (CPN) FHI 360 Gilead

National AIDS Memorial National HIV Classroom Learning Center, Project of CAI National Learning Center for HIV CB Leadership National Network to End Domestic Violence NMAC OraSure Technologies

HealthMerch

Positively Fearless from Janssen Pharmaceuticals, Inc.

Heart to Hand, Inc.

POZ / Smart & Strong

HIV.gov

Say it With a Condom

HRSA Ryan White HIV/AIDS Program Compass Dashboard

The AIDS Institute

Infectious Diseases Initiative at the O’Neill Institute International Community of Women Living with HIV Janssen Therapeutics, Division of Janssen Products, LP

Theratechnologies Valley AIDS Council Veru, Inc. ViiV Healthcare Warm Health Technology, Inc

#2021USCHA

7

What is SYMTUZA®?

• have not received anti-HIV-1 medicines in the past, or

as: dihydroergotamine, ergotamine tartrate, methylergonovine), ivabradine, lomitapide, lovastatin or a product that contains lovastatin, lurasidone, midazolam (when taken by mouth), naloxegol, phenobarbital, phenytoin, pimozide, ranolazine, rifampin, sildenafil when used for pulmonary arterial hypertension (PAH), simvastatin or a product that contains simvastatin, St.

• when their healthcare provider determines that they meet certain requirements.

John’s wort (Hypericum perforatum) or a product that contains St. John’s wort, or triazolam.

SYMTUZA® is a prescription medicine that is used without other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults and in children who weigh at least 88 pounds (40 kg) who:

HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS). It is not known if SYMTUZA® is safe and effective in children weighing less than 88 pounds (40 kg).

IMPORTANT SAFETY INFORMATION WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT SYMTUZA®?

SYMTUZA® can cause serious side effects including: • Worsening of hepatitis B virus infection. Your healthcare provider will test you for hepatitis B virus (HBV) before starting treatment with SYMTUZA®. If you have HBV infection and take SYMTUZA®, your HBV may get worse (flare up) if you stop taking SYMTUZA®.

• Do not stop taking SYMTUZA® without first talking to your healthcare provider.

• Do not run out of SYMTUZA®. Refill your prescription or talk to your healthcare provider before your SYMTUZA® is all gone.

• If you stop taking SYMTUZA®, your healthcare provider will need to check your health often and do blood tests regularly for several months to check your HBV infection or give you a medicine to treat your HBV infection. Tell your healthcare provider about any new or unusual symptoms you may have after you stop taking SYMTUZA®.

• Change in liver enzymes. People with a history of hepatitis B or C virus infection or who have certain liver enzyme changes may have an increased risk of developing new or worsening liver problems during treatment with SYMTUZA®. Liver problems can also happen during treatment with SYMTUZA® in people without a history of liver disease. Your healthcare provider may need to do tests to check your liver enzymes before and during treatment with SYMTUZA®.

• Serious problems can happen if you take any of these medicines with SYMTUZA® Before taking SYMTUZA®, tell your healthcare provider about all of your medical conditions, including if you: • have liver problems (including hepatitis B or hepatitis C), have kidney problems, are allergic to sulfa (sulfonamide), have diabetes, have hemophilia, or have any other medical condition.

• are pregnant (if you become pregnant while taking SYMTUZA®), or plan to become pregnant. It is unknown if SYMTUZA® will harm your unborn baby.

• SYMTUZA® should not be used during pregnancy.

• are breastfeeding or plan to breastfeed. Do not breastfeed if you take SYMTUZA®.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines interact with SYMTUZA®. Keep a list of your medicines to show your healthcare provider and pharmacist. Do not start taking a new medicine without telling your healthcare provider.

HOW SHOULD I TAKE SYMTUZA®?

• Take SYMTUZA® 1 time a day with food.

WHAT ARE THE POSSIBLE SIDE EFFECTS OF SYMTUZA®?

SYMTUZA® may cause serious side effects including: • See “What is the most important information I should know about SYMTUZA®?”

• Immune system changes can happen in people who start HIV medications.

• New or worse kidney problems, including kidney failure.

• Severe liver problems. In rare cases, severe liver problems can happen that can lead to death. Tell your healthcare provider right away if you get these symptoms:

• Your healthcare provider should do blood and urine tests to check your kidneys before you start and while you are taking SYMTUZA®.

• Skin or the white part of your eyes turn yellow

• Too much lactic acid is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat.

• Dark “tea-colored” urine • Light-colored stools • Loss of appetite for several days or longer • Nausea • Vomiting • Stomach area pain SYMTUZA® may cause severe or life-threatening skin reactions or rashes which may sometimes require treatment in a hospital. Call your healthcare provider right away if you develop a rash. Stop taking SYMTUZA® and call your healthcare provider right away if you develop any skin changes with symptoms below: • Fever • Tiredness • Muscle or joint pain • Blisters or skin lesions • Mouth sores or ulcers • Red or inflamed eyes, like “pink eye” (conjunctivitis) Who should not take SYMTUZA®?

• Do not take SYMTUZA® with any of the following medicines: alfuzosin, carbamazepine, colchicine (if you have liver or kidney problems), dronedarone, elbasvir and grazoprevir, ergot-containing medicines (such

• Too much lactic acid in your blood (lactic acidosis).

• Diabetes and high blood sugar (hyperglycemia). Some people who take protease inhibitors including SYMTUZA® can get high blood sugar, develop diabetes, or your diabetes can get worse. Tell your healthcare provider if you notice an increase in thirst or if you start urinating more often while taking SYMTUZA®.

• Changes in body fat can happen in people taking HIV-1 medications.

• Increased bleeding can occur in people with hemophilia who are taking SYMTUZA®.

The most common side effects of SYMTUZA® are: Diarrhea, rash, nausea, fatigue, headache, stomach problems, and gas.

These are not all of the possible side effects of SYMTUZA®.

Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http:// www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Janssen Products, LP at 1-800-JANSSEN (1-800-526-7736).

Please click here for full Product Information, including Boxed Warning for SYMTUZA®. cp-62077v5

© Janssen Therapeutics, Division of Janssen Products, LP 2021 10/21 cp-244843v1

You may report side effects to the FDA at 1-800-FDA-1088 or to Janssen Products, LP at 1-800-JANSSEN (1-800-526-7736).

Y With the right support you can take on anything. So whether you’re looking to start HIV treatment or are considering making a switch, you deserve a treatment that’s there for you at every step. Visit the virtual SYMTUZA® booth to learn more about one-pill, once-daily SYMTUZA®, then talk to your doctor about whether it could be right for you.

Visit the virtual SYMTUZA® booth for more information.

USCHA SPONSOR

Staff Executive Office Paul Kawata, Executive Director Kim Ferrell, Deputy Director of Operations

Development Robert York, Development Director Diane Ferguson, Development Associate

Conferences Tara Barnes-Darby, Director of Conferences Alison J. McKeithen, Assistant Director of Conferences Shanta’ Gray, Senior Registrar and Meeting Planner

Treatment Moisés Agosto-Rosario, Director of Treatment Damián Cabrera-Candelaria, Program Manager Jonathan Ayala, Program Coordinator

Communications Chip Lewis, Communications Director Dernell Green, Social Media Coordinator

Strategic Partnerships & Policy Joe Huang-Racalto, Director of Strategic Partnerships & Policy Andres Rodriguez, Advocacy Coordinator

NMAC Center to End the Epidemic Ken Pettigrew, Director of the Center Charles Shazor, Manager Terrell Parker, Program Manager Gabriella Spencer, Associate Program Manager Lauren Miller, Health Equity Program Coordinator Marshun Redmond, Administrative Assistant Cora Trelles Cartagena, HIV Systems Coordinator Christopher Paisano, Program CoordinatorIndian Country

Board of Directors Chair John W. Hill, Jr., Miami, FL Co-Chair Lance Toma, San Francisco Community Health Center, San Francisco, CA

Secretary Therese Rodriguez, Asian Pacific Islander Coalition on HIV/AIDS, New York, NY

Treasurer Valerie Rochester, Creating Healthier Communities, Washington, DC

Board Members Brenda Hunt Borderbelt AIDS Resource Team (BART) Lumberton, NC

Leonardo Ramon Ortega, MD, MPH Shalom Health Care Center, Inc. Indianapolis, IN

Rev. Ed Sanders Metropolitan Interdenominational Church Nashville, TN

Monica Johnson HEROES - Helping Everyone Receive Ongoing Effective Support Columbia, LA

Carlos E. Rodríguez-Díaz, PhD, MPHE, MCHES DC CFAR Milken Institute School of Public Health, George Washington University

Evelyn Ullah Broward County, FL

Kelsey Louie, MSW, MBA The Door and Broome Street Academy New York, NY

Mario Perez County of Los Angeles Department of Public Health Office of AIDS Programs & Policy Los Angeles, CA

Norm Nickens San Francisco, CA

Rodolfo R. Vega JSI Research & Training Institute, Inc. Boston, MA

USCHA Program Partners The AIDS Institute

Black AIDS Institute

AIDS United

International Association of Providers of AIDS Care

American Academy of HIV Medicine Association of Nurses in AIDS Care The Balm in Gilead

10

2021

UNITED STATES CONFERENCE ON HIV/AIDS

National AIDS Housing Coalition National AIDS Memorial

National Association of State and Territorial AIDS Directors Office of HIV/AIDS Network Coordination (HANC) Prevention Access Campaign U.S. People Living with HIV Caucus

DEC

2

SCHEDULE AT A GLANCE THURSDAY

All times are Eastern

10:00 am 12:00 pm 1:00 pm

MORNING DEVOTIONAL hosted by The Balm in Gilead

Opening Plenary Session

Federal Perspectives on HIV in the COVID Era

12:00 pm 5:00 pm

LOUNGES OPEN

1:15 pm 5:00 pm

VIRTUAL EXHIBIT HALL OPEN

1:15 pm 1:45 pm

Poster Presentations

Sex in the Time of COVID-19 Vaccines Having Our Say: Including Black Women in HIV Prevention

Facilitating Cooperation Between Syringe Service Programs (SSPs) and Law Enforcement (LE) in NYS

Simply Glow’d- Youth and Mental Health.

Putting the PharmD in Diabetes: comprehensive diabetes screenings in PWH

PASWHA National Study on HIV and Aging: Telehealth Lessons Learned

Outside the Guidelines: The HIV Continuum for People Experiencing Homelessness

Benefits of PrEP for Latino MSM: Implications for PrEP Messaging

Impacts of Housing on Health of People Living with HIV/AIDS

YOUNITY Workshop: An Essential Pivot in Response to a Pandemic

Viral Suppression: Achieving Equity By Partnering with Community SMEs

Sex Can Be Good, Why Can’t It Be Safe!

In San Francisco Empowering Black Youth Through Culturally Competent Sex-Ed

AFYA Project- Increasing PrEP Awareness Among African American Young Adults Aging and Womanhood: Empowering Mental Health Approach for Transgender Latina Same-day access to HIV prevention for people who inject drugs Improving Health Outcomes through Coordinated Care, Housing & Employment Services

Using Virtual Platforms to Promote Mental Health among PLWH HIV and COVID-19 Testing Innovations; A Year of Program Results.

HIV Testing Outcomes in CDC-Funded Health Departments During COVID-19

#2021USCHA

11

DEC

2

SCHEDULE AT A GLANCE THURSDAY Mental Health in American Indians and Alaska Natives with HIV/HCV

NY HIV programs and telehealth: lessons learned during the pandemic

Educating South Los Angeles Youth on HIV and Substance Abuse

2:30 pm 4:00 pm

Institute Session 1

Women Informing Now (WIN): Using Innovation to Reduce Isolation and Stigma among Women of Color living with HIV Presented by The AIDS Institute COVID, HIV, and Racism – How Providers Can Make a Difference Presented by AAHIVM Our People. Our Problem. Our Solution: Black in Action Presented by Black AIDS Institute 40 years of HIV inequities at home and abroad, where do we go next?

Presented by AIDS United

4:30 pm 5:30 pm

12

2021

Housing is Necessary for Ending HIV/AIDS Presented by NAHC and HUD Healing, Empathy, Relationships, Boundaries: Securing Your Bag (HERBS) Coordinated by NMAC TGNC CAP Navigating through A Transmasculine Lens Presented by the NMAC Transmasculine CAP How Men of Color Use Their Faith to Respond to HIV Related Trauma Presented by Balm in Gilead A Seat at the Table: Reimagining the Engagement of Systemically Affected Youth in SRH PSS Presented by the Youth CAP

Session 1 Workshops

SHERO: The Impact of Faith in Conversations with Women living with HIV

Impact of COVID-19 on HIV Prevention Services among CDC-funded CBOs

2020 Key Findings of RWHAP and EHE in Metropolitan Areas and Southern States.

Implementing a successful TelePrEP program, access, and adherence to PrEP

Bridging Gaps and Building Partnerships: HIV Elimination Among Tribal Communities

Making PrEP Truly Accessible to Black Gay/Bi/SGL/Queer Men

More Money, More Advocacy - Advocating for Federal HIV/AIDS Funding

Understanding the unique health needs of gender non-conforming adults

Strengthening the HIV Workforce in a Post-Pandemic World: Addressing Accessibility

Puerto Rico: Desarrollo de una evaluación de necesidades para la comunidad transgénero

Shifting to Action: Implementing Your ETE Plan

Mi Gente: HIV Latinx Prevention Program

The Networks of People Living with HIV Policy Agenda

Harm Reduction and Trauma-Informed Care: Competing or Complementary Approaches?

UNITED STATES CONFERENCE ON HIV/AIDS

DEC

2

SCHEDULE AT A GLANCE THURSDAY Triple Trouble: Addressing Stigmas of HIV, Viral Hepatitis, and SUD

Through the looking glass: prevention, treatment, and mental health lenses

Beyond 50 and Healthy, It’s Possible. Black, Bold, Beautiful, Thriving

Policy Approaches for Meeting the Needs of People Aging with HIV

Community-Academic Partnerships for Community-Based Participatory Research: Lessons from Chicago

HIV CURE - Hot Topics in HIV Cure Research

Engaging Black Women in Washington DC’s EHE Plan HOPWA 101 – What is HOPWA? From Surviving to Thriving in a Predominately White Institution

5:45 pm 6:45 pm

A Town Hall on Aging and HIV: A conversation with federal officials on providing adequate care and services for the older adult living with HIV Living with HIV and Hard Belly (Excess Visceral Abdominal Fat) Presented by Theratechnologies

Plenary Session

Self, Identity and Culture: How culture and identity shape and inform each other Sponsored by ViiV Healthcare

7:00 pm 8:00 pm

Special Event

“Fauci” documentary clip screening and panel discussion

#2021USCHA

13

DEC

2

THURSDAY

leadership & plenary

All times Eastern Standard Time

10:00 am - 11:00 am Morning Devotional

Morning Devotional Hosted by The Balm in Gilead Rev. Michael Schuenemeyer, Executive for Health and Wholeness Advocacy, United Church of Christ

12:00 - 1:00 pm EST Opening Plenary

Federal Perspectives on HIV in the COVID Era This year’s Opening Plenary will focus on the Federal response to HIV in the COVID environment. Dr. Anthony S. Fauci will give an update on the latest in HIV Treatment, vaccines and cure research. Harold Phillips, the Director of the White House Office of National AIDS Policy and the newly decorated four-star admiral in the Public Health Service, Dr. Rachel Levine will give a live address. They will discuss the Biden/Harris administration’s plan to end the HIV epidemic and the community’s role in its implementation.

Additionally, representatives from the PLHIV Caucus will discuss the importance of having a PLHIV federal policy agenda and the importance of quality of life. USCHA will honor House Speaker Nancy Pelosi for her tireless work championing HIV issues in Congress to effect positive change in the lives of persons living with HIV and AIDS. Speakers:

Fauci

Phillips

Levine

Johnson

Khanna

Misrok

Speaker of the House of Representatives Nancy Pelosi Dr. Anthony Fauci, Director, NIAID Harold Phillips, Director of The White House Office of National AIDS Policy (ONAP) Admiral Rachel Levine, MD, U.S. Assistant Secretary for Health Ronald Johnson, Chair, U.S. People Living with HIV Caucus Naina Khanna, Co-Executive Director, Positive Women’s Network - USA Mark Misrok, Executive Director, National Working Positive Coalition Cecilia Chung, Director of Evaluation and Strategic Initiatives, Transgender Law Center

12:00 pm - 5:00 pm Lounges

Lounges Open

14 14

2021

UNITED STATES CONFERENCE ON HIV/AIDS

Chung

Creating Possible For more than 30 years, Gilead has created breakthroughs once thought impossible for people living with life-threatening diseases. We are a leading biopharmaceutical company with a pioneering portfolio and ever-expanding pipeline of investigational medicines.

Our commitment goes well beyond science. We innovate with the goal of eliminating barriers and providing access to healthcare for people who need it most.

For more information, please visit www.gilead.com.

Gilead is proud to support USCHA 2021.

© 2021 Gilead Sciences, Inc.

DEC

2

THURSDAY

POSTER PRESENTATIONS

1:15 pm - 5:00 pm Exhibitions

Virtual Exhibit Hall Open

1:15 pm - 1:45 pm Poster Presentations

Sex in the Time of COVID-19 Vaccines Presenters:

Benefits of PrEP for Latino MSM: Implications for PrEP Messaging Presenters:

Ellen Almirol, MPH, MA, University of Chicago Medicine, Chicago, IL Aniruddha Hazra, MD, University of Chicago Medicine, Chicago, IL DeJuan Washington, MEd, University of Chicago Medicine, Chicago, IL Rey Flores, BSW, MA, University of Chicago Medicine, Chicago, IL

Ronald A. Brooks, Ph.D., UCLA Department of Family Medicine, Los Angeles, CA Omar Nietor, BA, UCLA Department of Family Medicine, Los Angeles, CA Martin Santillan, University of Southern California, Los Angeles, CA Track: Biomedical HIV Prevention

Jared Kerman, BS, University of Chicago Medicine, Chicago, IL Alan Nyitray, PhD, Medical College of Wisconsin, Milwaukee, WI Track: Addressing issues around COVID

YOUNITY Workshop: An Essential Pivot in Response to a Pandemic Presenters:

Having Our Say: Including Black Women in HIV Prevention Presenters:

Gina Brown, RSW, Southern AIDS Coalition, New Orleans, LA Nicole Beckwith, MPH, Duke University, Durham, NC Susan Reif, PhD, Duke University, Durham, NC

Sharita Ambrose, MPH, CHES, CHWI, Manor, TX

Track: Prioritizing People Living with HIV

La’Toya Swan, BS, CHES, CHWI Track: Biomedical HIV Prevention

Sex Can Be Good, Why Can’t It Be Safe!

Presenters:

Simply Glow’d- Youth and Mental Health Presenter: Ofelia Barrios, Iris House, Inc., New York, NY

Demisha Burns, Ph.D., MSW, Policy & Advocacy Manager, Women Organized to Respond to Life-threatening Diseases (WORLD), Oakland, CA

Track: Trauma-Informed Care

Erika Ramirez, Program Coordinator, The Latina Center, Richmond, CA Roger Jackson, Director of Programs, CAL-PEP, Oakland, CA Ingrid Floyd, Executive Director, WORLD, Oakland, CA Track: Racism and Race

PASWHA National Study on HIV and Aging: Telehealth Lessons Learned Presenters: Russell Bennett, Professional Association of Social Workers in HIV/AIDS, Birmingham, AL Kerry Littlewood, Professional Association of Social Workers in HIV/AIDS, Birmingham, AL Track: Best Practices in TeleHealth

16

2021

UNITED STATES CONFERENCE ON HIV/AIDS

AFYA Project- Increasing PrEP Awareness Among African American Young Adults Presenter: Kelsey Burton, MPH, University of Louisville, Louisville, KY Track: Biomedical HIV Prevention

POSTER PRESENTATIONS

THURSDAY

Aging and Womanhood: Empowering Mental Health Approach for Transgender Latina Presenters: Nathalie Tirado, Puerto Rican Cultural Center, Chicago, IL

DEC

2

Outside the Guidelines: The HIV Continuum for People Experiencing Homelessness Presenter: Jonathan Johnson, Cherokee Health Systems, Knoxville, TN Track: Ending the HIV Epidemic (EHE) - Next Steps

Sara Gonzalez, MA, MS, Puerto Rican Cultural Center, Chicago, IL Will O. Cobbs, Jr., PhD, MPH, Puerto Rican Cultural Center, Chicago, IL Track: Trauma-Informed Care

Same-day access to HIV prevention for people who inject drugs

Impacts of Housing on Health of People Living with HIV/AIDS Presenter: Rina Lubit, BA, New York State Department of Health, New York City, NY Track: Public Policy

Presenters: William Eger, MPH, Yale University School of Medicine, New Haven, CT Roman Shrestha, PhD, MPH, University of Connecticut, Storrs, CT Track: Biomedical HIV Prevention

Viral Suppression: Achieving Equity By Partnering with Community SMEs Presenters: Mario Mann, BETAH Associates, Rockville, MD

Improving Health Outcomes through Coordinated Care, Housing & Employment Services

Islam Tashi, BS, BETAH Associates, Rockville, MD Track: Ending the HIV Epidemic (EHE) - Next Steps

Presenter: Jessica Flaherty, Center for Innovation in Social Work & Health, Boston University School of Social Work, Boston, MA Track: Prioritizing People Living with HIV

In San Francisco Empowering Black Youth Through Culturally Competent Sex-Ed Presenter: Antwan Matthews, BS Youth Instructor, Code Tenderloin, San Francisco, CA Track: Racism and Race

Facilitating Cooperation Between Syringe Service Programs (SSPs) and Law Enforcement (LE) in NYS Presenters: Rachel Gullo, Law Enforcement Liaison, Office of Drug User Health, AIDS Institute, NYSDOH, New York, NY Maxine Phillips, Director of the Harm Reduction Unit (Retired July 2021), Office of Drug User Health, AIDS Institute, NYSDOH, New York, NY

Using Virtual Platforms to Promote Mental Health among PLWH Presenter: Karen McKinnon, Northeast/Caribbean AIDS Education and Training Center, New York, NY Track: Best Practices in TeleHealth

Track: Public Policy

Putting the PharmD in Diabetes: comprehensive diabetes screenings in PWH

HIV and COVID-19 Testing Innovations; A Year of Program Results.

Presenters:

Presenter: Joseph Olsen, CrescentCare, New Orleans, LA

Maya Hardman, PharmD, Southwest CARE Center, Santa Fe, NM

Track: Addressing issues around COVID

Bernadette Jakeman, PharmD, University of New Mexico, Albuquerque, NM Bianca Gonzales, PharmD, Southwest CARE Center, Albuquerque, NM Track: Prioritizing People Living with HIV

#2021USCHA

17

DEC

2

THURSDAY

POSTER PRESENTATIONS

HIV Testing Outcomes in CDC-Funded Health Departments During COVID-19

Educating South Los Angeles Youth on HIV and Substance Abuse

Presenter: Deesha Patel, MPH, Centers for Disease Control and Prevention, Atlanta, GA

Presenters:

Track: Addressing issues around COVID

Anthony Soria, St John’s Well Child and Family Center, Los Angeles, CA Herbert Hernandez, MFT Candidate, St John’s Well Child and Family Center, Los Angeles, CA Track: Racism and Race

Mental Health in American Indians and Alaska Natives with HIV/HCV Presenters: Colin Smith, MD, Department of Psychiatry and Behavioral Sciences and Department of Medicine, Duke University Medical Center, Durham, NC Jordan Kennedy, MSPH, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA Mary E. Evans, MD, MPH, Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA Marissa Person, MSPH, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA Rick Haverkate, MPH, Indian Health Service, Rockville, MD Andria Apostolou, PhD, MPH, Indian Health Service, Rockville, MD Track: Trauma-Informed Care

18

2021

UNITED STATES CONFERENCE ON HIV/AIDS

NY HIV programs and telehealth: lessons learned during the pandemic Presenter: Elys Vasquez-Iscan, Hostos Community College of the City University of New York, Bronx, NY Track: Best Practices in TeleHealth

SESSION 1 INSTITUTES

THURSDAY

DEC

2

2:30 PM – 4:00 PM EST Session 1 Institutes

Women Informing Now (WIN): Using Innovation to Reduce Isolation and Stigma among Women of Color living with HIV Presented by The AIDS Institute Presenters:

2. The learner will be able to identify new models that expand supportive networks of women of color with HIV to include those not currently engaged in care and ensure women are regularly engaged in healthcare while creating stronger community leadership among women with HIV. 3. The learner will be able to expand networks of women of color living with HIV to include those not currently engaged in care.

Dr. Ivy Turnbull, AIDS Alliance for Women, Infants, Children, Youth & Families, New York, NY Michelle Scavnicky, MS, The AIDS Institute, Tampa, FL WIN Micro-Grantees

Women living with HIV particularly women of color residing in rural areas and resource deserts often, experience intense isolation and barriers to medical care and supportive services. Women Informing Now (WIN), a micro-grant initiative supports grassroots, women-led community-based organizations and leaders conducting innovative approaches that reduce isolation and stigma for women of color living with HIV. This potentially powerful and cost-effective model targets up to sixteen (16) projects in geographical areas across the country with the highest burden of HIV as highlighted in the Ending the HIV Epidemic: A Plan for America, with a special emphasis placed on women with HIV living in rural areas and “resource deserts” not connected to care. The WIN initiative is dedicated to reducing isolation and stigma often experienced by women of color with HIV, improving health outcomes through expanding and strengthening organizational networks that support women’s health, increasing the engagement of women of color across the HIV prevention and care continuum and designing innovative strategies of engagement of women of color with HIV. The basic element of this innovative model enhances opportunities to develop networks of support focused on the needs of women living with HIV, leverage existing women-focused resources to engage women who are disconnected from healthcare and supportive care systems, and develop leadership among women to address typical barriers that women of color with HIV face to access quality care and supportive service delivery systems.

The Women Informing Now (WIN) micro-grant initiative supports grassroots, women-led community-based organizations and leaders conducting innovative approaches that reduce isolation and stigma for women of color living with HIV, with a special emphasis placed on women with HIV living in rural areas and “resource deserts” not connected to care.

Learning Outcomes 1. The learner will be able to identify social networks of support, engagement, and trust among women of color living with HIV

COVID, HIV, and Racism – How Providers Can Make a Difference Coordinated by the American Academy of HIV Medicine Presenters: Gary F. Spinner, PA, MPH, AAHIVS, Bridgeport, CT Kenric Ware, PharmD, Columbia, SC Howard K. Wutoh, PhD. RPh, Provost Howard University, Dean of Howard University School of Pharmacy, Washington, DC Moderator: Amber McCracken, American Academy of HIV Medicine, Washington, DC

COVID-19 and HIV have exposed significant systemic racism and medical mistrust with U.S. healthcare system. The American Academy of HIV Medicine will offer an interactive workshop to discuss 1) the lessons learned from COVID and HIV epidemics; 2) how systemic racism and medical mistrust impact access to prevention and care options for people of color; and 3) how medical providers can ameliorate medical mistrust among patients affected by COVID and/or HIV, while advancing solutions for eliminating systemic racism in the healthcare field. We will discuss efforts to recruit minority students to enter healthcare, explore the challenges people of color face in achieving leadership positions in this field and discuss creative ideas for helping healthcare providers of all races become part of the solution to ending systemic racism in healthcare.

Our People. Our Problem. Our Solution: Black in Action Presented by the Black AIDS Institute

We have soldiered on through multiple pandemics and epidemics, triumph and tragedy, and we resisted and survived; something that is all too familiar for Black communities. This, however, begs the question, ‘where are we now?’ Join BAI and Prevention Access Campaign (PAC) for a collective check-in. We’ve had a pause, and it is time to regain

#2021USCHA

19

DEC

2

THURSDAY

momentum. During this interactive session, we will all contribute to a community action plan which serves to uplift the needs of the community, and name what we require of the EHE strategy moving forward. You will leave this institute with action steps for engaging different institutions within your community so that we can ensure that we are not only Black in Action, but on the forefront of change and liberation.

40 years of HIV inequities at home and abroad, where do we go next?

Presented by the AIDS United Speakers: Alejandro Acosta, Director of Policy Southern AIDS Coalition, Powder Springs, GA Drew Gibson, Senior Policy Manager, Harm Reduction and HIV, Washington, DC Kelly Stevens, Director of Capacity Building, AIDS United, Washington, DC

While the federal government has a detailed roadmap to end the HIV epidemic (EHE), due to COVID-19, it has become clear that more coordinated efforts are needed at the state and local level that align with and enhance the federal plan that now only covers 57 jurisdictions.

To address this, AIDS United will host an Institute comprised of interactive sessions regarding key state policies impacting HIV prevention, care and treatment, advocacy strategies and methods for building capacity. The Institute would include: •

Three interactive plenary sessions: 1) State related policies addressing barriers; 2) advocacy including partnership development; and 3) capacity building.

•

Breakouts after each session, where attendees will discuss what was heard and report out their thoughts and recommendations to the full audience.

Those who attend the Institute will gain new/enhanced skills, knowledge, and tools for developing innovative plans for advancing coordinated state policy and advocacy.

SESSION 1 INSTITUTES

The Housing is Necessary for Ending HIV/AIDS workshop describes how housing is one of the keys to ending the HIV/AIDS epidemic. Highlights include the presentation of research that describes housing is an effective structural intervention and that there is a positive relationship between stable housing and access to care and maintenance of care. Further, housing reduces HIV risk and improves health outcomes among PLWH. Finally, unmet housing needs are a significant barrier to accessing and maintaining appropriate HIV Medical Care.

Healing, Empathy, Relationships, Boundaries: Securing Your Bag (HERBS) Coordinated by NMAC TGNC CAP

This institute will focus on best practices for self-care and how to prioritize your own self-care need. We will also discuss tips on how attendees can help others prioritize their needs as well. Communal Healing will take center stage as attendees are guided through dialogue and facilitation on how to take care of the community you live in. As we know hurt and healing affects everyone; how do you use your power as a leader to help others heal?

Objectives: •

Attendees will identify elements currently within their personal selfcare toolkit for healing.

•

Attendees will examine elements of their self-care toolkit to assist in empathizing with their community, strengthening relationships.

•

Attendees will correlate self-care and its importance to establishing or sustaining relationships. (Personal & Professional)

•

Attendees will connect struggles with establishing healthy boundaries, and how to hold strong to them.

•

Attendees will tap into their leadership skills to best scale themselves for employment or working for self to tell their story while utilizing what they learned from objectives 1-4.

Navigating through A Transmasculine Lens Housing is Necessary for Ending HIV/AIDS

Presented by the Transmasculine CAP

Presented by National AIDS Housing Coalition and HUD

This institute will consist of personal journeys of transmasculine individuals and their experiences. Speakers will discuss what it looks like being a transmasculine elder person either reactive or non-reactive. Also, being a transmasculine person born with HIV navigating life. Additionally provide experiences being transmasculine reactive and having carried a child, reproductive health, and basic yearly examinations.

Presenters: Rita Harcrow, Director OHH, HUD, Washington, DC Lauren Banks Killelea, Director of Policy & Advocacy, National AIDS Housing Coalition Kate Briddell, HIV Housing & Health Program Manager, Collaborative Solutions, Inc., Tacoma, WA

20

2021

UNITED STATES CONFERENCE ON HIV/AIDS

Get the SCOOP on injectable CABENUVA Don’t miss the CABENUVA Good to Know Event at this conference to learn about an injectable treatment option.

Hear more inspiring stories at CABENUVA.com ©2021 ViiV Healthcare or licensor.

CBROGM210081 October 2021 Produced in USA.

Steve

Hiker Avid traveler On CABENUVA Compensated by ViiV Healthcare.

Click “Workshops” in the menu bar to join. You’ll hear Steve’s story about life on CABENUVA and get firsthand information from a healthcare professional.

DEC

2

THURSDAY

SESSION 1 INSTITUTES

How Men of Color Use Their Faith to Respond to HIV Related Trauma

A Seat at the Table: Reimagining the Engagement of Systemically Affected Youth in SRH PSS

Presented by Balm in Gilead

Presented by the Youth CAP

HIV continues to impact men of color at alarming rates. Although they represent a small percentage of the United States population, African Americans still account for a much larger share of HIV diagnoses and deaths among people with HIV than any other racial/ethnic group.

Meaningful youth engagement is based on the principle that young people have a right to be heard in matters that affect them. Engaging youth in the design, implementation, and evaluation of policies, programs, and systems that impacts their lives is believed to support young people’s development, strengthen programs, services and organizations, and benefit society socially, politically, and economically. Despite widespread support, sexual health interventions are rarely designed, delivered, and evaluated with support from young people the interventions intend to target. Many existing youth engagement strategies lack rigorous evidence of their ability to engage youth meaningfully and impact health outcomes.

Furthermore, the sexual health field lacks a coordinated and mobilized effort for disseminating effective youth engagement strategies to reduce disparities or unintended pregnancies and sexually transmitted infections.

In this interactive workshop we will explore youth engagement strategies used across sexual and reproductive health programs, services, and system change efforts; share key learnings from youth and youth-serving stakeholders; and discuss gaps and opportunities for innovation in the field of youth engagement in sexual and reproductive health programs, services, and system change efforts.

With these unsettling statistics, many have leaned on their faith to combat the trauma provoked by their HIV diagnoses and HIV-related stigma. As research in-dicates, individuals living with HIV are more likely to have significant trauma and comorbid medical conditions which directly impacts their quality of life, mental stability and emotional health.

Faith plays a vital role in addressing HIV-related trauma.

This session will identify essential opportunities and skills places of worship can adopt to become more trauma informed and look at solutionbased approaches to implement in efforts to respond to HIV-related trauma and build strategic com-passionate care programs for congregants who are impacted by HIV.

4:30 PM – 5:30 PM EST Session 1 Workshops

SHERO: The Impact of Faith in Conversations with Women living with HIV Presented by Balm in Gilead

2020 Key Findings of RWHAP and EHE in Metropolitan Areas and Southern States Pathway: HRSA

Pathway Faith

Presenters: Pamela Klein, HRSA/HAB, Rockville, MD

Moderator: Kelly E. Wagner, Center for Technical Assistance, Training, and Research Support, The MayaTech Corporation

As a federal leader in Ending the HIV Epidemic Initiative in the U.S. (EHE), the Health Resources and Services Administration’s (HRSA) Ryan White HIV/AIDS Program (RWHAP) has a critical role in linking people who are either newly diagnosed with HIV, or diagnosed but currently not in care, to essential HIV care, treatment, and support services. These services help people with HIV access care and treatment to reach viral suppression and reduce HIV transmission. Using innovative strategies to link and re-engage people with HIV to essential medical and support services is a vital component of achieving the goals of the EHE initiative. The learning objectives for this session are: (1) describe the role of HRSA in EHE, (2) estimate the number of new and re-engaged clients served by HAB EHE recipients, and (3) summarize and discuss key activities, challenges, and accomplishments of HAB EHE recipients and providers in their implementation of the EHE initiative.

For many, faith has been the pillar of one’s everyday journey. They lean to faith to overcome many obstacles, especially related to health and wellness. This session will highlight the impact that faith plays in addressing issues regarding women and HIV. The panel will share stories on how women have been empowered through engagement and building community.

22

2021

UNITED STATES CONFERENCE ON HIV/AIDS

SESSION 1 INSTITUTES

THURSDAY

DEC

2

Bridging Gaps and Building Partnerships: HIV Elimination Among Tribal Communities

Strengthening the HIV Workforce in a PostPandemic World: Addressing Accessibility

Track: Racism and Race Level: Beginner

Track: Addressing issues around COVID Level: Intermediate

Presenters:

Presenter: Carsen Beckwith, AIDS United, St. Louis, MO

Erika Alfaro, MPH, CAI Global, New York, NY

The COVID-19 pandemic brought to light many inequities faced across human rights in our nation. As the option to work in collaborative office spaces and care environments became less viable, leaders began transitioning their organizational work and systems. The general public required new and accessible means of work, leading organizations to adopt virtual and flexible systems that were rooted in decades-old recommendations from disability justice advocates.

Miguel Chion, MD, MPH, CAI, Los Angeles, CA Savannah Gene, MS, CHES, National Native HIV Network and the Albuquerque Area Indian Health Board, Albuquerque, NM Kurt Begaye, National Native HIV Network and the Albuquerque Area Indian Health Board, Albuquerque, NM Rick Haverkate, Indian Health Service, Fort Lauderdale, FL

American Indian and Alaska Native (AI/AN) communities impacted by HIV are disproportionally affected, particularly in their lack of access to HIV services. In addition, the HIV service organizations serving these communities have minimal access to capacity-building opportunities such as training and technical assistance. The National Native HIV Network, the Indian Health Service (IHS), and CAI Global have found an opportunity to bridge the existing gap and create a meaningful partnership. This interactive workshop will increase participants’ knowledge of HIV prevention efforts in the AI/AN community. The presenters will also share their perspectives on HIV prevention, detail their proposed plan to bridge the capacity-building gap, and share their progress towards their goals.

This workshop will also provide participants with opportunities to ask questions and share experiences.

Presenters will examine the access considerations that must be kept at the forefront as we transition into a post-pandemic world. Attendees will be able to explore best practices based in disability justice for the support of the HIV workforce. These will include such topics as telehealth and telework options; utilizing integrated virtual platforms; standardized translation and closed captioning services; remote or flexible professional development for staff and advocates; and more. Presenters will provide participants with strategies that can be applied following the conference.

Shifting to Action: Implementing Your ETE Plan Track: Ending the HIV Epidemic (EHE) - Next Steps Level: Intermediate Presenters: Kennedy Bradley, MSW, AIDS Foundation Chicago, Chicago, IL

More Money, More Advocacy - Advocating for Federal HIV/AIDS Funding Track: Public Policy Level: Intermediate Presenters: Nick Armstrong, The AIDS Institute, Washington, DC Stephanie Hengst, The AIDS Institute, Washington, DC

This workshop will focus on the federal funding needed for domestic HIV programs, especially in the context of the Ending the HIV Epidemic (EHE) Initiative. This workshop will focus on federal funding for domestic HIV/AIDS programs, teaching workshop participants about the federal appropriations process, how funding is allocated for these programs, and how to advocate for increased funding. Now more than ever, federal investments in HIV programs impact how CBOs, state, and local health departments and other ASOs deliver services to their clients. Policy advocates, Congressional staff and federal grantees will present discuss recent and current federal appropriations and budget cycles will be discussed, including the impact of the Ending the HIV Epidemic Initiative and COVID-19 on funding for HIV programs will be analyzed. Participants will gain a greater understanding of the federal appropriations landscape and will be provided tools for engaging in community advocacy for HIV programs.

Writing a thoughtful and affirming ETE plan is a huge accomplishment, and yet, it’s just the beginning of an incredibly challenging journey.

Implementing your plan requires thoughtfulness, collaboration and, ultimately, resources. How will you shift your jurisdiction’s ETE plan from theory to action? How will you best mobilize community, maximize strengths and encourage resource sharing within your network? How will you talk about and quantify the work that you do as an ETE team? This interactive workshop will include both individual and group activities to help participants explore ways to strengthen the current structure of their jurisdiction’s ETE plan. The facilitator will share both the highs and lows of the Getting to Zero Illinois (GTZ-IL) team’s first year of implementation including lessons learned and best practices. Participants will have the opportunity to share their own experiences, troubleshoot with other ETE leaders and draft a theory of change for their jurisdiction to ground future decision-making.

#2021USCHA

23

DEC

2

THURSDAY

SESSION 1 WORKSHOPS

The Networks of People Living with HIV Policy Agenda

Implementing a successful TelePrEP program, access, and adherence to PrEP

Track: Public Policy Level: Advanced Presenter:

Track: Best Practices in TeleHealth Level: Intermediate Presenter: Rene Cotto-Lewis, 26health, Orlando, FL

Martha Cameron, International Community of Women Living with HIV North America, Washington, DC

PrEP is a vital component of the prevention strategy that’s part of America’s Ending the HIV Epidemic Plan. PrEP has been FDA approved since 2012, but uptake and adherence remains extremely low. One key barrier to PrEP uptake is accessibility, and thus PrEP has remained out-of-reach to many individuals, in both rural and urban areas. TelePrEP (telemedicine) can remove this main barrier to access by eliminating the need for in-person provider visits every three months. This workshop will allow the audience to hear from multiple organizations that have implemented TelePrEP in different parts of the country. The audience will learn how their organization can start or expand their current PrEP programs utilizing telemedicine, while also leveraging their 340B status to create a sustainable program of offering free online PrEP and STI testing within their community.

What do people living with HIV want from a federal HIV response? In 2010, the Obama administration released the National HIV/AIDS Strategy (NHAS); a decade later, the Trump administration released the third iteration of NHAS, renamed the HIV National Strategic Plan (HNSP), and aligned with the Ending the HIV Epidemic (EHE) federal initiative, to achieve the goal of ending the domestic HIV epidemic by 2030.

For decades, networks of people living with HIV have advocated for a national HIV strategy that goes beyond a biomedical response to the epidemic, incorporating quality of life and care for people living with HIV and meaningful involvement in its planning and implementation. 40 years into the epidemic and people living with HIV are still not involved in meaningful ways in developing federal policy.

This workshop will highlight the federal policy agenda by networks of people living with HIV.

Making PrEP Truly Accessible to Black Gay/Bi/ SGL/Queer Men Track: Biomedical HIV Prevention Level: Beginner Presenters:

Impact of COVID-19 on HIV Prevention Services among CDC-funded CBOs Track: Addressing issues around COVID Level: Intermediate Presenters: Jarvis Carter, Centers for Disease Control and Prevention, Atlanta, GA

In 2020, CDC conducted two assessments with 118 community-based organization (CBOs) recipients of PS15-1502 and PS17-1704 on how COVID-19 impacted daily operations and the provision of HIV prevention services. Although the majority of CBOs encountered challenges with meeting program objectives and providing services during the onset of COVID-19, CBO recipients devised and implemented strategies to avoid a major reduction in critical HIV prevention services. This workshop will highlight how COVID-19 impacted operations and key HIV prevention services (e.g., HIV testing, HIV linkage to care, etc.). Workshop participants will have an opportunity to learn and engage with CDC presenters on various innovative strategies implemented during the COVID-19 pandemic to overcome challenges, discuss HIV prevention models that assist with continuity of services, and other valuable lessons learned.

Kenyon Farrow, PrEP4ALL, Cleveland Heights, OH

Nine years after the FDA approved the first drug for HIV prevention, we still see very low PrEP usage among Black gay, bisexual, same-gender loving and queer identified men. As a result, the racial disparity in HIV diagnoses is getting wider, not smaller. This workshop will be an opportunity for PrEP navigators and Black men on PrEP primarily to talk about what’s working in local PrEP access and linkage programs, and what are the needs that still need to be met to increase PrEP usage.

Understanding the unique health needs of gender non-conforming adults Track: Treatment and Research Level: Beginner Presenters: Taylor Lensch, PhD, MPH, University of Nevada Reno, Nevada Public Health Training Center, Reno, NV Trudy Larson, MD, Institute for Health Impact and Equity, University of Nevada, Reno, NV Jay Cafferata, MA, Institute for Health Impact and Equity, University of Nevada, Reno, NV Gerold Dermid, MBA

24

2021

UNITED STATES CONFERENCE ON HIV/AIDS

SESSION 1 WORKSHOPS

THURSDAY

Gender non-conforming adults are disproportionately impacted by HIV, sexual risk behaviors, substance use, and mental health problems compared to gender conforming adults. Further, gender non-conforming adults often experience significant barriers to care and are subject to greater levels of discrimination and abuse. There is a dire need for states and localities to conduct formative assessments to understand the needs of this population to reduce barriers to care and to improve health and well-being. In this workshop, presenters will share how the Nevada Public Health Training Center established a partnership with state and local partners to address the health needs of gender diverse adults in the state, focusing specifically on HIV. Our presentation will review the development, implementation, and results from the Hope Grows for Transgender Health needs assessment implemented across Nevada in December 2020.

Puerto Rico: Desarrollo de una evaluación de necesidades para la comunidad transgénero Track: Track en español Level: Beginner Presenters: Arianna Lint, Arianna’s Center, Fort Lauderdale, FL

La comunidad transgénero de Puerto Rico experimenta tasas desproporcionadas de discrimi-nación y falta de acceso a atención médica, vivienda y empleo en comparación con la población en general.

La violencia contra las personas trans también es una realidad que la comunidad enfrenta a diario, tanto así que el gobernador declaró recientemente el estado de emergencia en respuesta a la cantidad de asesinatos de alto perfil de personas trans en los últimos 12 meses. Para abordar estos problemas, es esencial un mayor acceso a los servicios sociales y mayores recursos, entre ellos la financiamiento, pero la falta de data a menudo crea barreras para asegurar este apoyo. En respuesta, el Arianna’s Center con la orientación de la Universidad de Puerto Rico llevó a cabo una evaluación de necesidades a gran escala de la comunidad transgénero de Puerto Rico en 2020 para comprender mejor los problemas que afectan sus vidas. Este estudio contó con el aporte de más de 300 personas en todo Puerto Rico, que re-presentan una sección transversal diversa de la comunidad.

DEC

2

from English), meaning it was designed for Spanish speakers, prioritizing the Latinx population of Indianapolis with goals to decrease stigma surrounding HIV/AIDS and increase access to HIV prevention services. “Mi Gente” consists of three components: education, outreach, and primary care services which includes a Spanish PrEP campaign, community engagement, HIV screening & counseling, and PrEP services. “Mi Gente’s” goals align with the Ending the HIV Epidemic (EHE) by promoting public health and enhancing quality of life through prevention, intervention, and treatment of HIV. “Mi Gente” continues to be funded through community foundation and state EHE support. The audience will take away strategies on breaking barriers and increasing methods of accessibility for the Spanish speaking Latinx community.

Harm Reduction and Trauma-Informed Care: Competing or Complementary Approaches?

Track: Trauma-Informed Care Level: Beginner Presenter: Katie McCormick, SUSTAIN COMPASS Coordinating Center, Houston, TX

The social and structural conditions of the South (i.e., policies, stigma, racism, homophobia, lack of access to care) continue to drive the HIV epidemic, particularly among Black and Latinx communities. Harm reduction (HR) is rooted in the understanding that structural oppression and social inequities impact individuals markedly, and as such, aims to reduce harm at the individual, community and systemic levels. While HR is largely known for its focus on reducing the negative consequences associated with drug use, HR is also about how services are provided. Like trauma-informed care (TIC), HR is a relational, client-centered approach that can transform client-provider relationships in that it calls for nonjudgmental, non-coercive provision of services. This workshop will focus on bridging the connection between HR and TIC, and equip attendees with knowledge and skills needed to practice an integrated approach in their respective organizations.

Triple Trouble: Addressing Stigmas of HIV, Viral Hepatitis, and SUD Mi Gente: HIV Latinx Prevention Program Track: Racism and Race Level: Intermediate Presenters: Angie Martinez, Shalom Health Care Center, Indianapolis, IN Staci Walters, Shalom Health Care Center, Indianapolis, IN

Shalom Health Care Center, a federally qualified health center, will present on its culturally competent Spanish HIV Prevention Program titled “Mi Gente”. “Mi Gente” is a Spanish first program (not translated or interpreted

Track: Prioritizing People Living with HIV Level: Beginner Presenter: Amanda Morgan, Community Education Group, Bruceton Mills, WV

Plainly stated, the explanation for West Virginia’s (WV’s) ongoing outbreaks of HIV and viral hepatitis is stigma—from HIV and the escalating rates of substance use disorder (SUD). These concurrent stigmas stop people from seeking HIV and viral hepatitis testing, which hides the severity of the outbreaks and leads to diminished resources for opt-out testing, HIV care and disease tracking. Stigmatizing attitudes toward people with SUD has increased legislative action to curb or shut down the harm reduction

#2021USCHA

25

DIMITRI LIVING WITH HIV SINCE 2018 REAL BIKTARVY PATIENT

KEEP ASPIRING. Because HIV doesn’t change who you are.

BIKTARVY® is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in certain adults. BIKTARVY does not cure HIV-1 or AIDS.

Ask your healthcare provider if BIKTARVY is right for you.

Featured patient compensated by Gilead.

Watch Dimitri’s story at BIKTARVY.com

IMPORTANT FACTS FOR BIKTARVY®

This is only a brief summary of important information about BIKTARVY and does not replace talking to your healthcare provider about your condition and your treatment.

MOST IMPORTANT INFORMATION ABOUT BIKTARVY BIKTARVY may cause serious side effects, including: � Worsening of hepatitis B (HBV) infection. Your healthcare provider will test you for HBV. If you have both HIV-1 and HBV, your HBV may suddenly get worse if you stop taking BIKTARVY. Do not stop taking BIKTARVY without first talking to your healthcare provider, as they will need to check your health regularly for several months, and may give you HBV medicine.

ABOUT BIKTARVY BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 55 pounds.

It can either be used in people who have never taken HIV-1 medicines before, or people who are replacing their current HIV-1 medicines and whose healthcare provider determines they meet certain requirements.

BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS. Do NOT take BIKTARVY if you also take a medicine that contains: � dofetilide � rifampin � any other medicines to treat HIV-1 POSSIBLE SIDE EFFECTS OF BIKTARVY BIKTARVY may cause serious side effects, including: � Those in the “Most Important Information About BIKTARVY” section.

(bik-TAR-vee)

� Changes in your immune system.

Your immune system may get stronger and begin to fight infections that may have been hidden in your body. Tell your healthcare provider if you have any new symptoms after you start taking BIKTARVY. � Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. If you develop new or worse kidney problems, they may tell you to stop taking BIKTARVY. � Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat. � Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain. � The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%).

These are not all the possible side effects of BIKTARVY. Tell your healthcare provider right away if you have any new symptoms while taking BIKTARVY. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Continued on next page.

Please see Important Facts, including important warnings, continued on the next page and at BIKTARVY.com.

ZACH

D’EVA

HUGO

CHAD

NIKKI

DIMITRI

Meet a few of the extraordinary people who take BIKTARVY.

Watch their stories at BIKTARVY.com Featured patients compensated by Gilead.

IMPORTANT FACTS FOR BIKTARVY® (CONTINUED) Your healthcare provider will need to do tests to monitor your health before and during treatment with BIKTARVY. BEFORE TAKING BIKTARVY Tell your healthcare provider if you: � Have or have had any kidney or liver problems, including hepatitis infection. � Have any other health problems. � Are pregnant or plan to become pregnant. It is not known if BIKTARVY can harm your unborn baby. Tell your healthcare provider if you become pregnant while taking BIKTARVY. � Are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed. HIV-1 can be passed to the baby in breast milk.

Tell your healthcare provider about all the medicines you take: � Keep a list that includes all prescription and over-the-counter medicines, antacids, laxatives, vitamins, and herbal supplements, and show it to your healthcare provider and pharmacist.

� BIKTARVY and other medicines may affect each other. Ask your healthcare provider and pharmacist about medicines that interact with BIKTARVY, and ask if it is safe to take BIKTARVY with all your other medicines.

HOW TO TAKE BIKTARVY Take BIKTARVY 1 time each day with or without food.

GET MORE INFORMATION � This is only a brief summary of important information about BIKTARVY. Talk to your healthcare provider or pharmacist to learn more. � Go to BIKTARVY.com or call 1-800-GILEAD-5 � If you need help paying for your medicine, visit BIKTARVY.com for program information.

Please see Important Facts, including important warnings, above and at BIKTARVY.com.

BIKTARVY, the BIKTARVY Logo, GILEAD, the GILEAD Logo, KEEP ASPIRING, and LOVE WHAT’S INSIDE are trademarks of Gilead Sciences, Inc., or its related companies. Version date: February 2021 © 2021 Gilead Sciences, Inc. All rights reserved. US-BVYC-0060 11/21

Capacity Building Assistance Provider Network: Strengthening the Nation’s HIV Prevention Workforce

The Capacity Building Assistance (CBA) Provider Network (CPN) implements capacity-building programs and services for CDC-funded health departments, community-based organizations (CBOs), and healthcare providers to enable the HIV prevention workforce to optimally plan, integrate, implement, and sustain comprehensive programs and services that will help achieve the nation’s HIV prevention goals.

The CPN offers:

National Training through two National HIV E-learning Centers and a National HIV Classroom Learning Center.

Regional Technical Assistance

Regional Technical Assistance (TA) for CDC-funded health departments and CBOs in four geographic regions: Northeast, South, Midwest, and West.

Regional TA focuses on clinical HIV testing and prevention for persons with HIV, nonclinical HIV testing and prevention for HIV-negative persons, and integrated HIV activities and structural interventions.

National Learning Community for HIV CBO senior- and mid-level program managers at CDC-funded CBOs. Learning community includes expert instruction, mentoring, and resource sharing as well as peer-to-peer learning and support.

Find more details and information on how to access services at: https://www.cdc.gov/hiv/capacity-building-assistance/index.html

DEC

2

THURSDAY

services needed to prevent outbreaks in the first place. In response, WV’s Community Education Group (CEG) and partners have adapted an educational series to reduce stigma and increase support for harm reduction services among multiple stakeholders, including front-line providers, emergency service workers and law enforcement. Participants will learn the barriers and facilitators of adapting an effective stigmareducing education.

Beyond 50 and Healthy, It’s Possible. Black, Bold, Beautiful, Thriving Track: Prioritizing People Living with HIV Level: Beginner Presenter: Joseph Robinson, THRIVE SS, Atlanta, GA

Are you over 50 years of age? African American Male? Living with the virus?

Do you feel alone and secluded? Are you a long-term survivor and didn’t think you would make it this far? The Silver Lining Project is an intervention developed for African American Men over the age of 50 and living with HIV. The curriculum leverages the voices and lived experiences of the mature same gender loving men to disseminate information and drive conversation designed to help reduce the effects of stigma and promote self-efficacy and advocacy. The facilitators will discuss the challenges and oppressive forces our community experiences and the impacts these have on the mind, body and soul. The attendees will participate in an interactive activity that will explore their social identities followed by a discussion on how these identities contribute to conversations that help reduce stigma and promote self-efficacy.

Community-Academic Partnerships for Community-Based Participatory Research: Lessons from Chicago Track: Treatment and Research Level: Beginner Presenters: Pedro A. Serrano, MPH, CPH, Cook County Health, Chicago, IL Ricardo Albarran, MPH, CHES, QRAL Group, Chicago, IL Daniel Mendez, Puerto Rican Cultural Center, Chicago, IL

Through the Ending the HIV Epidemic (EHE) Plan for America, the National Institutes of Health has enabled the Centers for AIDS Research (CFAR) to provide otherwise inaccessible resources for researchers, including those from disadvantaged backgrounds, such as racial, ethnic, sexual and gender minority backgrounds. CFAR resources are a boon to community practitioners and health researchers working on local EHE initiatives, especially where community engagement is needed to adapt and tailor strategies, such as for Latinx sexual and gender minorities. Community-

30

2021

UNITED STATES CONFERENCE ON HIV/AIDS

SESSION 1 WORKSHOPS

academic partnerships are mutually beneficial relationships which allow both practitioners and academicians the opportunity to conduct community-based participatory research (CBPR) that may otherwise be difficult to accomplish without collaboration. However, partnerships require intentional relationship building, alignment of purpose, transparency, and accountability. In addition, capacity building and technical assistance may be required to prepare partners to conduct CBPR. This workshop will share lessons learned from community-engaged work underway in Chicago, IL.

Engaging Black Women in Washington DC’s EHE Plan Track: Ending the HIV Epidemic (EHE) - Next Steps Level: Intermediate Presenter: Camilla Stanley, DC Health, Washington, DC

The District of Columbia (DC) Ends HIV Ending the HIV Epidemic (EHE) plan rests on the four pillars of the federal “Ending the HIV Epidemic: A Plan for America” initiative — Diagnose, Treat, Prevent, Respond — and adds a fifth: Engage. In order to achieve the plan’s goal of fewer than 130 new HIV diagnoses per year in the District, it is important to understand the needs of the communities we serve. This session will specifically focus on Black women, who represent the second highest category of new HIV diagnoses in DC. Of those persons diagnosed with HIV between 2015 and 2019, one in four was a Black woman. In this session, we will outline the community engagement activities conducted with Black women and share examples of how the information gathered is used to inform HIV prevention programs and initiatives, using the examples of the District’s Post Exposure Prophylaxis (PEP) Hotline and Black Women’s Health Initiative.

HOPWA 101 – What is HOPWA? Pathway: Housing Presenters: Rita Harcrow, Director Office of HIV/AIDS Housing, HUD Washington, DC Kate Briddell, HIV Housing & Health Program Manager, Collaborative Solutions, Inc., Tacoma, WA

The Housing Opportunities for Persons With AIDS (HOPWA) Program is the only Federal program dedicated to the housing needs of people living with HIV/AIDS. Under the HOPWA Program, HUD makes grants to local communities, States, and nonprofit organizations for projects that benefit low-income persons living with HIV/AIDS and their families. The HOPWA 101 session will cover HOPWA implementation topics, including: program eligibility; documentation; HOPWA eligible activities; managing rental assistance; financial administration; monitoring; and other program details.

SESSION 1 WORKSHOPS

THURSDAY

From Surviving to Thriving in a Predominately White Institution Pathway: Structural Interventions

BIPOC represent the majority of PLHIV in the United States with Black/African Americans being the most impacted by scope & scale.

Predominately White Institutions (federal, state, local, private and nonprofits) are the most well-funded often wielding the greatest impact. For those BIPOC who work in PWI’s focused on serving the communities that they represent and others, tools are needed to maintain and achieve one’s vocational goals.

Objectives: 1) Learn metrics of demographics of leadership within HIV response; 2) Best practices to support oneself/community within a PWI; 3) Creating systems to improve recruitment & hiring of BIPOC; 4) Discuss best ways forward to DISMANTLE systemic racism across HIV response **Disclaimer: Please be mindful that this session should be a space exclusively dedicated to BIPOC**

HIV CURE - Hot Topics in HIV Cure Research Track: Treatment and Research Level: Intermediate Presenters: Moises Agosto Rosario, Director of Treatment, NMAC, Washington, DC

DEC

2

and facilitators of participation in HIV cure related research, inclusion of diverse populations like transgender women, Latinx, and Youth, participant perspectives of HIV cure research, and analytic treatment interruptions and partner protection measures to minimize secondary HIV transmissions among sexual partners.

Through the looking glass: prevention, treatment, and mental health lenses.

Pathway: SAMHSA Presenters: LCDR Katie Hager, SAMHSA Center for Mental Health Services, Rockville, MD Anthony Bethea, SAMHSA Center for Substance Abuse Prevention, Rockville, MD Dr. Ed Craft, SAMHSA Center for Substance Abuse Treatment, Rockville, MD

]The Substance Abuse and Mental Health Services Administration (SAMHSA) will facilitate this session reflecting on the conference theme of homecoming: remembrance, reconnection and celebration, through grant programing and highlighting the work of SAMHSA grantee recipients who are addressing individuals living with HIV or at risk of HIV. This session will provide a glimpse through the SAMHSA lenses of prevention, treatment, and mental health services. Each lens provides a unique perspective and myriad of services that are evidence-based and benefit clients and communities. Please join grantees and their corresponding Federal SAMHSA Program Officials as they share their unique perspectives from the local community and federal level.

Danielle M. Campbell, Research Faculty, Charles R. Drew University of Medicine and Science, Los Angeles, CA Dr. Luis Montaner, Vice President, Scientific Operations, Associate Director for Shared Resources, The Wistar Institute Cancer Center, Philadelphia, PA Cecilia Chung, Senior Director of Strategic Initiatives and Evaluation of Transgender Law Center, Washington, DC Manuel Venegas, defeatHIV Community Advisory Board, Fred Hutchison Cancer Research Center, Seattle, WA

Policy Approaches for Meeting the Needs of People Aging with HIV Pathway: Aging Presenters: Jax Kelly, Let’sKick ASS Palm Springs, Palm Springs, CA

William Carter, Chair of the Delaney BEAT-HIV Community Advisory Board, Community Engagement Support, University of Pennsylvania, Philadelphia, PA

Melanie Reese, Older Women Embracing Life, Baltimore, MD

HIV in the United States continues to disproportionately impact racial/ ethnic minority and sex and gender diverse populations. That includes Black and Latinx communities, gay and bisexual/men, women, and transgender persons. In 2019, Black and Latinx communities comprised an astounding 71% of the new HIV diagnoses in the US but represented less than that of the total US population. It goes without saying that when an HIV cure becomes available, these groups should be prioritized among those who need a cure. The session aims to provide an update on the latest in HIV CURE related research, and discuss critical issues that affect how research is conducted and non-inclusive of all populations affected with HIV. In addition, faculty will discuss ethical issues including barriers

More than half of the people living with HIV in the United States are aged 50 and beyond. The burdens of HIV, aging, and related health comorbidities, combined with the social and structural challenges that people aging with HIV face, neces-sitate focusing on HIV-related outcomes and a comprehensive response aimed at treating comorbidities and improving long-term health and quality of life. This session will discuss the need for policy actions to generate complete responses and enhance the health of older people living with HIV.

Sean Bland, O’Neill Institute for National andGlobal Health Law, Washington DC

#2021USCHA

31

DEC

2

THURSDAY

A Town Hall on Aging and HIV: A conversation with federal officials on providing adequate care and services for the older adult living with HIV Presenters: Dr. Maureen Goodenow, NIH Office of AIDS Research Dr. Laura Cheever, HAB, HRSA Edwin Walker, HHS Administration on Aging Harold Phillips, White House Office of National AIDS Policy

Advancing on developing adequate care and services for the older adult living with HIV requires continuous dialogue between federal officials heading critical federal agencies and the community of people living and aging with HIV over the age of 50. This virtual town hall brings them together in the spirit of collaboration and productive discussions as we work on and advocate for adequate care and services for this growing population.

PLENARY SESSION

Policy Approaches for Meeting the Needs of People Aging with HIV Pathway: Aging Presenters: Jax Kelly, Let’s Kick ASS Palm Springs, CA Melanie Reese, Older Women Embracing Life, Baltimore, MD Sean Bland, O’Neill Institute for National and Global Health Law, Washington DC

More than half of the people living with HIV in the United States are aged 50 and beyond. The burdens of HIV, aging, and related health comorbidities, combined with the social and structural challenges that people aging with HIV face, neces-sitate focusing on HIV-related outcomes and a comprehensive response aimed at treating comorbidities and improving long-term health and quality of life. This session will discuss the need for policy actions to generate complete responses and enhance the health of older people living with HIV.

5:45 - 6:45 PM EST Plenary Session

Self, Identity and Culture: How culture and identity shape and inform each other Sponsored by ViiV Healthcare

Culture plays a critical role in resolving the tension between how we are seen and how we see ourselves – and if we create nuanced and accurate cultural portrayals of identity and experience, we have an opportunity to reduce stigma and change perception - impacting everything from HIV to institutional inequality.

This session will explore how BIPOC and LGBTQ identities are shaped (and maintained) in mainstream culture and how exploring these identities serves as a mechanism for bringing us together.

Moore

Johnson

Jones

Valles

Moderator: Darnell Moore, Director of Inclusion Strategy for Content & Marketing at Netflix Panelists: George Johnson, Award-Winning Black Non-Binary Writer, Author, and Activist Imara Jones, Creator of TransLashMedia Jesus I. Valles, Educator, Storyteller, and Performer

7:00 PM EST Film Screening

“Fauci” Clip Screening and Panel Discussion NMAC, Picture Motion, and National Geographic will convene frontline and healthcare workers and HIV/AIDS activists to view a select clip of FAUCI, a feature length documentary that chronicles the life of Dr. Anthony Fauci, world-renowned infectious disease specialist. After the clip screening, we will host a panel discussion about the film, Dr. Fauci’s role in the 1980s HIV/AIDs epidemic, and what progress has been made leading up to today.

32

2021

UNITED STATES CONFERENCE ON HIV/AIDS

DEC

3

SCHEDULE AT A GLANCE FRIDAY

10:00 am 11:00 am

MORNING DEVOTIONAL hosted by The Balm in Gilead

10:00 am 11:00 am

PRE-CONFERENCE SESSION

11:00 am 12:00 pm

The Journey to 400,000: Leaving No One Behind

Session 2: Workshops

The COVID-19 Pandemic: Impact on Southern HIV Service Organizations, Staff and Client

Creating Coalitions to Address the SUD, HIV, and Hepatitis Syndemic

HOPWA 201 – Program Updates

Tried To Make Me Go To Rehab: TIC and Addiction

Sponsored by Gilead Sciences

The Faith Factors: Implicit Bias and Faith The CABENUVA (cabotegravir; rilpivirine) Good to Know Event Presented by ViiV Healthcare

Leveraging COVID-19 Lessons and Infrastructure of Hepatitis Perseverance spelled R-E-S-I-L-I-E-N-C-E: Effective Community Engagement by National CFAR CAB Fortalecimiento institucional para proveedores Latinx en los tiempos del COVID-19 Accessing Buprenorphine through TeleHealth: Transcending Barriers for Rural/Underserved Communities

340B, Drug Pricing, ETE, Program Income – Critical Advocacy Intersections The “Showing Up for Black Power, Liberation and Healing” Initiative Addressing HIV Disparities: Experiences from the end+disparities ECHO Collaborative PrEP4Teens: Empowering Youth to Create Their Own Social PrEP Marketing Trauma Informed Management: Strategies for Supporting a Weary Workforce

Addressing Health Equity Issues to Expand HIV Prevention & Treatment Access and Choice

Lessons learned: Implementing the TWIST intervention as a retreat

Health Equity for Black Women Living with HIV

Healing Together, an adaptation of Common Threads© : Combating HIV-Related Stigma and Improving ART Adherence

Presented by Merck

Launching Chicago’s First Comprehensive HIV HUB : Lessons Learned & COVID-19

12:00 pm 5:00 pm

ENGAGE: Strengthening and Sustaining Meaningful Health Department and Community Relationships

LOUNGES OPEN

#2021USCHA

33

DEC

3

SCHEDULE AT A GLANCE FRIDAY

12:00 pm 1:00 pm

1:00 pm 5:00 pm 1:15 pm 2:15 pm

Plenary Session

Voices of Resilience: Forging Progress and Urgency in Challenging Times (Presented by Gilead) VIRTUAL EXHIBIT HALL OPEN

Session 3: Workshops

The Importance of Testing and Care in Helping End the HIV Epidemic Presented by Gilead

Blessings and Barriers: Using storytelling to challenge traditional narratives about HIV, sexuality and faith Making the HOPWA Program Work for Your Community Trends in HIV Diagnoses, Care and Viral Suppression Among Hispanic/Latinx and Challenges in Addressing the HIV Epidemic Among Hispanic/Latinx in the Deep South.

Harm Reduction (More Than Just Syringe Exchange)

2021

Respuesta Comunitaria al COVID-19 en Latinx en los Estados Unidos Latinx Transgender Voices to inform HIV Care and Prevention Services From the Polls to Policy: Centering Community in HIV/LGBTQIA+ Advocacy Recruiting & Retaining Men of Color for Remote PrEP Project The Power Dynamics of MIPA in HIV Criminalization

Challenges and Innovations in Rural Sexual Health

Facilitating Posttraumatic Growth and Resilience in HIV Care Settings

Rapid ART Start: Improving HIV Engagement and Care

Telehealth and HIV Self-Testing: Improving Your “Website Manners!”

Innovative Responses in Nutrition for People Living with HIV

Femme Noire Invisible: Uncloaking the HIV+ Cisgender Black Woman

Trauma-Informed Leadership and Supervision: A Time to Rethink Leadership

Pivot, Adapt and Rise: “These are the same issues…just worse”

Advocating for Increasingly Aggressive Management of HIV/HCV Co-infection in PWID

Understanding Black Men: Culture, Stigma, Sexuality and Getting-to-Zero

Interrupting Stigma where HIV & Opioid Use Disorder Intersect

Stakeholder-driven approach to improving HIV PrEP awareness among university students

The Benefits of Telehealth Extend Beyond the Pandemic

34

Internalized HIV-related Stigma in Women of Color Obtaining Care

UNITED STATES CONFERENCE ON HIV/AIDS

DEC

3

2:30 pm 3:30 pm

SCHEDULE AT A GLANCE FRIDAY Session 4: Workshops

National Institutes of Health, Office of AIDS Research: Listening Session with OAR Director Dr. Maureen Goodenow Office of AIDS Research (OAR), Rockville, MD Nothing Left Unsaid: Keeping it 100 with Your Care Team Presented by Janssen Therapeutics Funding Housing: HOPWA, Ryan White, and More Coalition Building for Sustained Response Adolescent Sexual Health and HIV/STD Telemedicine Services During the COVID-19 Pandemic Community Engagement: Leading change to end the HIV epidemic in the midst of COVID 19 HIV Status Neutral: Paradigm shift for the HIV prevention and care cycle Social marketing campaign for HIV self-testing during COVID-19 and beyond Successful Strategy to Engage YMSMC to Telehealth PrEP Building Rapid-Response Surveys to Strengthen Your Organization From Glitz to Glam: Native STD/HIV Prevention Increasing PrEP Uptake: When a Clinic Feels Like a “Casita” ¿PrEParadx para el futuro?: Métodos innovadores para prevenir el VIH

Adapting In-Person Interventions for Virtual Delivery Elevating Critical Conversations on Breastfeeding and HIV Pharmacists and HIV Prevention: A Perfect Match!

Arts as Resistance for Black, Latinx, & Indigenous LGBTQ+ communities Collaborative Language: the Intersection of HIV, Substance Use, and Incarceration It’s About Time - HIV Research Just for Transgender Women Providing Care along the Virtual Continuum of PrEP Care End HIV 901: Achieving Health & Harmony in Memphis When the Party is over: A conversation about sex, chems, HIV and mental health Moving forward, grantee lessons learned and valuable resources from SAMHSA Policy Approaches for Meeting the Needs of People Aging with HIV Older Adults with HIV: Awareness and management of common co-occurring condition 40 years of Resilience & Thriving Calling for Change: Reports from the Convening on HIV and Employment

#2021USCHA

35

WHAT WE LIVE FOR, HEALTHYSEXUAL, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc. © 2020 Gilead Sciences, Inc. All rights reserved. UNBC7495 12/20

It will take all of us working together to address the stigmas and disparities that fuel the HIV epidemic.

By working hand in hand with the community, we are working to break down the barriers that stand in the way of people feeling accepted, seeking the care they need, and being their true selves.

Together we are helping correct common misperceptions and silencing the stigmas around HIV. We are spreading the word through local community events and educational programs such as Healthysexual® and Stop the Virus.

Together we are lifting each other up until HIV is no more.

GILEAD IS A PROUD SPONSOR OF USCHA 2021 GileadHIV.com @gileadhivus @GileadHIVUS

DEC

3

SCHEDULE AT A GLANCE FRIDAY

4:00 pm 5:30 pm

5:45 pm 6:45 pm

Institutes

This is Our Story: HIV Impact and Opportunities in the Rural South Presented by: Southern AIDS Coalition

United We Rise: What would the response to HIV look like if it were led by Black people Presented by United We Rise

The ABC’s of Building a Local Long-Term HIV Survivor Network Presented by The Reunion Project

Keeping Our Circle Strong: Effective Collaborations for AI/AN Community Presented by the American Indian/ Alaska Native CAP

Sin voz, ni voto: The hidden victims of the intersection of Covid-19, Crystal Meth, and HIV in our Latino communities Presented by the Latinx CAP

Advocate, Tell Your Story, Advocate!

Presented by National AIDS Housing Coalition and HUD

Closing Plenary Session

Foundation Stones to Building the EHE Effort in Indian Country Presented by American Indian/Alaska Native CAP

38

2021

Asian Communities: Surviving the Colliding Pandemics Presented by the Asian CAP

UNITED STATES CONFERENCE ON HIV/AIDS

SESSION 2 WORKSHOPS

FRIDAY

DEC

3

All times Eastern Standard Time

10:00 AM - 11:00 AM Morning Devotional

Morning Devotional Hosted by The Balm in Gilead Rev. Michael Schuenemeyer, Executive for Health and Wholeness Advocacy, United Church of Christ

10:00 AM - 11:00 AM Pre-Conference Session

The Journey to 400,000: Leaving No One Behind Moderator: Deondre B. Moore - U.S. Partnerships & Community Engagement Manager, Prevention Access Campaign Powered by Theratechnologies

The Journey to 400,000, the next phase and initiative of the Prevention Access Campaign (United States), is a public health initiative to increase viral suppression among the estimated 400,000 people in the U.S. living with HIV who are not yet virally suppressed. This will be accomplished through testing and treatment initiatives, education and outreach, awareness campaigns, strengthening the HIV workforce, and advocacy efforts. The purpose of this “breakfast session” is to introduce “The Journey to 400,000” initiative and discuss various components of the initiative with a diverse panel of experts in the field of HIV to highlight the importance of this initiative and explain how viral suppression will bring us closer to ending the HIV epidemic in the United States.

11:00 AM - 12:00 PM EST Session 2: Workshops

The COVID-19 Pandemic: Impact on Southern HIV Service Organizations, Staff and Client Sponsored by Gilead Sciences Moderator: Christopher Mathews, Program Manager, Emory COMPASS Coordi-nating Center Presenters: Susan Reif, Research Scholar, Duke University Haley Cooper, Project Coordinator, Duke University Panelists (2-3 Agency Reps) – TBD

Community-based organizations (CBO) are critical in addressing HIV through prevention and care services, particularly in the Deep South, a region that has been disproportionately affected by HIV, and where public resources including medical care, culturally affirming providers, and support services are often lim-ited.1-4 CBOs are also positioned to address COVID-19 but may suffer from nega-tive financial and structural effects that limit their ability to offer critical services.5,6 The Duke Center for Health Policy and Inequalities Research in partnership with the Southern AIDS Coalition developed and disseminated a survey from January to June 2021, to CBOs, including Gilead COMPASS Initiative® partners, regarding the impact of the COVID-19 pandemic on their organizations related to service availability and disruption, organizational changes and needs, and staff and client impact and needs.

This session will highlight the findings of this study, with a particular focus on the mental health repercussions experienced by organizational staff and clients as told through the stories of COMPASS partners.

HOPWA 201 – Program Updates Pathway: Housing Presenter: Rita Harcrow, Director Office of HIV/AIDS Housing, HUD, Washington, DC

Key HUD staff and subject matter experts will cover recent program events and activities including CARES Act, HOPWA Modernization, recent awards, new federal and program initiatives, and a look ahead.

The Faith Factors: Implicit Bias and Faith Pathway: Faith Presenters: Shyla K. Fields, Moderator, Program Manager, Office of Identity, Inclusion and Collective Conscious, University of Alabama at Birmingham Pastor Neville Lendor, Amazing Grace Seventh Day Adventist Church, Brooklyn, NY W. Imara Canady, Vice-President of Strategic Partnerships and Programs, National Center for Civil and Human Rights Kamal Fizazi, CEO & Founder, Azimuths Consulting LLC

Implicit bias is the term used to describe when we have attitudes towards

#2021USCHA

39

DEC

3

FRIDAY

people or associate stereotypes without our conscious knowledge. While this has been a common factor of life for many throughout generations, the impact of these attitudes based on gender, race, sexual orientation and HIV status toward others can be a tremendous burden.

This session will describe implicit bias and how faith communities can and are responding. Attendees will be given an opportunity to share solutionbased approaches to adapting strategic ways to address implicit bias in various faith settings.

The CABENUVA (cabotegravir; rilpivirine) Good to Know Event Presented by ViiV Healthcare Presenters: Brittany Alexander, DNP, ViiV Healthcare Community Medical Liaison Steve H., Patient Ambassador

It’s not every day you learn about an injectable treatment option, like CABENUVA! Join us for an educational program to learn all about CABENUVA. Come hear from real people who are currently on CABENUVA, and a medical expert who reviews the safety and efficacy data from clinical trials.

Learning Objectives: •

The unknown challenges of taking pills in our community

•

What it’s like to be on CABENUVA from a real person’s perspective

•

Who might be a good fit for CABENUVA

Leveraging COVID-19 Lessons and Infrastructure for Hepatitis Pathway: Hepatitis Level: Intermediate Presenters:

SESSION 2 WORKSHOPS

to respond to future infectious disease outbreaks are done so in a way to equitably support the efforts and end goal of eliminating current infectious disease epidemics like viral hepatitis. This workshop will look at innovative care models that incorporate lessons learned from COVID-19, and what further infrastructure building is needed for a stronger, equitable public health system.

Perseverance spelled R-E-S-I-L-I-E-N-C-E: Effective Community Engagement by National CFAR CAB Track: Treatment and Research Level: Beginner Presenter: Danielle M. Campbell, UCLA/CDU, Los Angeles, CA

Effective community engagement has led to the development of landmark scientific advances in HIV clinical research. Since its inception, the National Centers for AIDS Research (CFAR) Community Advisory Board (CAB) Coalition (N3C) has served as the community engagement and advocacy arm of the more than 18 CFARs located at academic and research institutions throughout the United States. CFARs are a program within the National Institutes of Health with administrative and shared research support to synergistically enhance and coordinate high quality HIV/AIDS research. We, a diverse group of national advocates living with and affected by HIV/AIDS, utilize a multi-disciplinary approach to provide space for community and other key stakeholders to meet, define scientific priorities, and share best practices for community engagement within CFARs. This session will discuss evidence-based strategies needed to define and operationalize constructs of meaningful community engagement as we work to end the HIV epidemic.

Fortalecimiento institucional para proveedores Latinx en los tiempos del COVID-19

Rita K. Kuwahara, Georgetown University, Washington, DC

Track: Track en español Level: Intermediate Presenter(s):

Katie Burk, End Hep C SF, San Francisco, CA

Miguel Chion, MD, MPH, CAI, Los Angeles, California

Christine Simon, Kelsa Lowe, National Nurse-Led Care Consortium, Philadelphia, PA

Arismendi Jimenez, MD, CAI, New York, New York

Emily Waterman, Philadelphia Department of Public Health, Philadelphia, PA Tomoko Udo, New York State Department of Health, Albany, NY

The nation’s response to COVID-19 shone a spotlight on the cracks and missing pieces of the United States’ health care infrastructure, especially as it relates to combating infectious diseases. The hepatitis community has long struggled with similar barriers such as educating individuals about the need to stay safe against viral hepatitis, ensuring robust access to testing, expanding vaccine coverage, and linking those living with viral hepatitis to timely treatment. Elimination can’t be achieved if we leave people behind. It is imperative that the systems being built now

40

2021

UNITED STATES CONFERENCE ON HIV/AIDS

Erika Roca, MPH, CAI Los Angeles, California

Ponerle fin a la epidemia del VIH en los EEUU requiere un esfuerzo concertado, sostenido y equitativo. Históricamente, las organizaciones que sirven a la población latina reportan dificultades de acceso a experiencias de fortalecimiento institucional. La pandemia del COVID 19, contribuye y potencia dichas barreras. ¿Cómo podemos lidiar con estas barreras?

Durante esta sesión CAI presentará su experiencia de proveer fortalecimiento institucional a pesar de la pandemia del COVID 19.

Durante este taller se revisará las limitaciones que los proveedores de servicios VIH a la población latina enfrentan: el acceso a cursos en español, la falta de materiales culturalmente apropiados, el efecto del COVID 19

FRIDAY

SESSION 2 WORKSHOPS

y el pobre acceso a tecnología necesaria para los cursos remotos. CAI presentará un marco conceptual (matriz) de cómo se están enfrentando dichas barreras, el portafolio de cursos en español, así como también los resultados y lecciones aprendidas de esta experiencia.

Accessing Buprenorphine through TeleHealth: Transcending Barriers for Rural/Underserved Communities Track: Best Practices in TeleHealth Level: Intermediate Presenters: Narelle Ellendon, NYSDOH, AIDS Institute, Office of Drug User Health, New York, NY Lisa Skill Rachel Gullo

The unprecedented disruption to our healthcare system caused by the COVID-19 pandemic has brought the need for enhancing telemedicine options across all systems into even sharper focus. Telemedicine has been a practical and life-saving option for provision of buprenorphine, particularly in rural areas or areas that have shortages of waived practitioners authorized to provide buprenorphine. Telemedicine provides quality care across distances to some of the most underserved communities, such as people living with an Opioid Use Disorder (OUD) and HIV in rural areas. Telemedicine for the provision of buprenorphine aims to ensure that individuals with OUD presenting in clinical and nonclinical settings have timely access to this medication.

New York State Department of Health released their guidance in April 2021 for accessing buprenorphine through telemedicine to inform medical providers on how to use telemedicine for buprenorphine provision, where the patient presents at a setting that does not have waived providers.

DEC

3

disproportionately limit certain patient populations’ ability to access the prevention and treatment options that suit their individual needs. As issues of health equity and social determinants of health (SDoH) rise in priority in the U.S., there is an opportunity for stakeholders working in HIV to stem policy-driven and structural inequities that drive the persistent disparities in HIV outcomes.

In this session, diverse stakeholders from the HIV and policy communities will break down the existing factors that underpin and amplify inequities affecting HIV prevention and treatment and will discuss forward-looking solutions to address these inequities.

Learning objectives: •

Raise awareness of the inter-related, systemic factors – including restrictive policies – that contribute to disparities in access and choice of HIV prevention and treatment options.

•

Highlight solutions and best practices that can address the systemic inequities affecting HIV patient groups.

•

Galvanize the HIV community to collaborate on solutions that protect patients’ ability to access and choose the HIV prevention and treatment therapies that suit their individual needs.

Health Equity for Black Women Living with HIV Track: Prioritizing People Living with HIV Level: Intermediate Presenters: Cecilia Flores-Rodríguez, PhD, University of Massachusetts, Lowell, MA Linda Sprague Martinez, PhD, MSW, Boston University, Boston, MA Mo Wahome, MPH, AIDS Care Group’s Black Women’s Health Initiative, Philadelphia, PA Nicole Johnson, MPH, MBA, City of Philadelphia’s SHE Program, Philadelphia, PA Angela Wangari Walter, PhD, MSW, University of Massachusetts, Lowell, MA

Addressing Health Equity Issues to Expand HIV Prevention & Treatment Access and Choice Presented by Merck Speakers to be confirmed.

The stakeholder groups that will be represented in the session include: •

Patient advocates

•

ASO representatives

•

Healthcare providers, patient educators, and/or allied healthcare professionals

•

Policymakers and/or federal agencies

At its core, access to and choice of HIV prevention and treatment options is a health equity issue. Restrictive policies and systemic inequities in health care settings – which often manifest as bias, racism, and stigma – can

Serena Rajabiun, PhD, University of Massachusetts, Lowell, MA

The Black Women First (BWF) Initiative aims to implement culturally responsive and evidence informed bundled interventions to meet the unique health needs of Black women living with HIV. Funded by the Health Resources and Services Administration (HRSA) under the Special Projects of National Significance (SPNS), BWF is being carried out by 12 demonstration sites around the USA. Members of the evaluation and technical assistance provider (ETAP) along with staff members from two demonstration sites will lead participants through the decisions made and structures put into place to launch these interventions. Participants will have the opportunity to engage in co-learning with demonstration sites about the factors that drove their intervention design as well as implementation strategies aimed at standing up interventions to improve health equity for Black women.

#2021USCHA

41

DEC

3

FRIDAY

SESSION 2 WORKSHOPS

Launching Chicago’s First Comprehensive HIV HUB: Lessons Learned & COVID-19

Tried To Make Me Go To Rehab: TIC and Addiction

Track: Addressing issues around COVID Level: Beginner Presenters:

Track: Trauma-Informed Care Level: Intermediate Presenters:

Anthony Guerrero, MS, AIDS Foundation Chicago/HIV Resource HUB, Chicago, IL

Rachel Hughey, LSW, Nationwide Children’s Hospital, Columbus, OH

Jill Dispenza, Center on Halsted/HIV Resource HUB, Chicago, IL Brandi Calvert, AIDS Foundation Chicago/Center for Housing and Health, Chicago, IL Jennifer Jimenez, AIDS Foundation Chicago/Center for Housing and Health, Chicago, IL Carmen Corredor, Center on Halsted/HIV Resource HUB, Chicago, IL

The HIV Resource Coordination HUB launched on February 14, 2020. The HUB was designed and is run in collaboration between AIDS Foundation Chicago and local community partners, dedicated to providing a one-stopshop for HIV-related care and LGBTQ+ affirming services to the greater Chicagoland area. One month after launch, the COVID-19 epidemic hit the United States. Celebrating over one year of service, The HUB has now served and responded to thousands of requests for support, providing COVID-19 relief and essential HIV services to clients across the area. Learn from the leaders of The HUB as they discuss the formation of the HUB and the impacts of the pandemic on the communities served, as well as lessons learned from the experiences of launching an innovative public health program amidst a pandemic.

Creating Coalitions to Address the SUD, HIV, and Hepatitis Syndemic Track: Public Policy Level: Beginner Presenters: Marcus J. Hopkins, External Affairs Manager, Community Education Group, Morgantown, WV A. Toni Young, Founder & Executive Director, Community Education Group, Morgantown, WV

West Virginia has been ravaged by Substance Use Disorders (SUDs) for much of the past thirty years, beginning with the prescription opioid addiction epidemic, heroin addiction, and currently, a resurgence of methamphetamine addiction. SUDs have led to overdose death and an HIV and Viral Hepatitis syndemic. This workshop will highlight the work performed by the Community Education Group in the 2020 creation of the West Virginia Statewide Stakeholder Coalition (WVSSC). The WVSSC is a coalition of over 140 constituents including people with lived experience, Community-Based Organizations, government agencies and departments, healthcare providers, insurers, and pharmaceutical partners. With between 40-70 attendees each month, the WVSSC is one of the largest working coalitions in the state of West Virginia dedicated to deconstructing the silos that exist between SUD, HIV, and Viral Hepatitis screening, testing, and linkage to care, treatment, and services.

42

2021

UNITED STATES CONFERENCE ON HIV/AIDS

Angela Billingslea, LISW-S, Nationwide Children’s Hospital, Columbus, OH

This training is a Trauma Informed Care (TIC) workshop focusing on Addiction and HIV. Starting with the basics on how language stigmatizes, this workshop moves quickly into the science of addiction and treatment.

The facilitators provide a brief, evidence-based overview of trauma, including how substance use disorders (SUD) and alcohol, tobacco, and other drugs (AOD) use can cause trauma and/or assist in coping with trauma.

ENGAGE: Strengthening and Sustaining Meaningful Health Department and Community Relationships Track: Ending the HIV Epidemic (EHE) - Next Steps Level: Intermediate Presenter: Jacobi Hunter-Wright, AIDS United, Dallas, TX

Your jurisdiction needs to strengthen its community relationships in order to operationalize community voices in their Ending the HIV Epidemic (EHE) plans. How do you meaningfully engage and involve communities that have expressed distrust and trauma with health systems? Further, how can these relationships be sustained while centering trust? EHE jurisdictions must begin the prioritization of meaningful and mutually beneficial partnerships with their focus population community stakeholders. This is a key element of the EHE strategy. Its emphasis is reflected in the CDC guidance that at least one-fourth of EHE-awarded funds be used to support the intentional engagement of community organizations in EHE plan development and implementation activities. Challenges historically posed require approaches that focus on rebuilding and restoring trust as an integral part of strengthening overall engagement. The ENGAGE Model is a community-informed approach to strengthening and sustaining EHE phase 1 health departments and community relationships.

340B, Drug Pricing, ETE, Program Incone- Critical Advocacy Intersections Track: Public Policy Level: Intermediate Presenter: Bill Keeton, Vivent Health, Milwaukee, WI

The intersections of several key public policy decision points in Congress and the Administration, as well as recent actions by the pharmaceutical

WE ARE THERA COMMUNITY

We are dedicated to building safe space with timely relevant education and resources for the HIV Care Community.

THERA COMMUNITY PROGRAMS THERAThursdays are the third Thursday every month,

>>> HIV Discussion Guide 1. Do you know when your last viral load and CD4 count were?

Yes or No If yes, what was the approximate date? _________________________________________________ 2. Was your viral load undetectable?

Yes or No If your viral load was not undetectable, what was your viral load? ____________________ 3. What was your last CD4 count? _______________________________________________ 4. What are the names of your HIV medications? _________________________________________________ _________________________________________________ _________________________________________________ 5. Are you having challenges taking your medication?

Yes or No If yes, describe these challenges: _________________________________________________

8. Do you know why you changed your HIV medications?

Yes or No If yes, then why did you change your HIV medications? ___________________________________________

Your Belly Discussion Guide

___________________________________________

Each month Thera recognizes a Community Champion, someone doing exceptional work in the HIV community, with a $1000 sponosorship for the organization that they work or volunteer.

Nominate or Vote for your champion at TheraThursdays.com

___________________________________________ 9. Do you have any other health care concerns (Behavioral health, Substance abuse, Diabetes, COVID-19, Hypertension, Hepatitis)?

Yes or No If yes, what are your concerns? ___________________________________________ ___________________________________________ ___________________________________________

_________________________________________________ 6. Are you following the instructions your healthcare provider gave you on how to take your HIV medications?

Yes or No If no, what is different about how you take your HIV medications? _________________________________________________ _________________________________________________ _________________________________________________ 7. Have you changed your HIV medications in the past?

Yes or No If yes, how many times have you changed your HIV medications? _________________________________________________

If your viral load is not undetectable,

SCHEDULE AN APPOINTMENT WITH YOUR HEALTHCARE PROVIDER TO DISCUSS WHY. • Ask your healthcare provider why your viral load is detectable and if there are treatment options that can get your virus undetectable.

• Ask your healthcare provider if you need resistance testing.

• Refer to the Understanding HIV and Resistance Brochure.

For more information go to HIVandResistance.com

THERA

technologies 000-00-07/20

HIV Discussion Guide

Learn how to utilize our patient-friendly guides to improve your clients’ ability to discuss their body changes and HIV drug resistance with their providers.

45 MINUTE EDUCATIONAL PROGRAMS Detailed descriptions below.

ATTEND THESE EDUCATIONAL PROGRAMS TO FIND OUT MORE

Our Understanding HIV and Resistance RESISTANCE program includes a review of Ending the HIV Epidemic goals, overview of U=U, a discussion on reasons regimens fail, the need for new treatments, a quick review of Trogarzo®, and resources to educate and empower patients.

Understanding HIV and

>>>>>

>

where we bring timely relevant educational programs to the HIV Care Community - Case Managers, Social Workers, Linkage Coordinators and Peer Educators. We hope this information will help you serve your clients. Past topics include Cultural Humility; Resiliency in Vulnerable populations; The Importance of Support; HIV and Influenza/COVID. Click here to register for our next THERAThursdays

Register by clicking the link here: HIVandResistance.com

Our My Hard Belly program includes a discussion on conditions affecting our aging HIV population, including weight gain and excess visceral fat (hard belly). It includes tips to stay healthy, ways to identify hard belly, and tools to equip the patient for a conversation with their provider.

Register by clicking the link here: HIVandYourBelly.com

To connect with the Thera Community Team please email us at community@theratech.com.

DEC

3

FRIDAY

industry and insurance companies, will have far-reaching and profound impacts on access to critical HIV prevention, healthcare, social services and medication assistance programs. This workshop will discuss the potential impacts of these decisions as well as the advocacy initiatives underway to ensure people affected by HIV continue to receive the care and services they need.

SESSION 2 WORKSHOPS

Addressing HIV Disparities: Experiences from the end+disparities ECHO Collaborative Track: Ending the HIV Epidemic (EHE) - Next Steps Level: Intermediate Presenters: Clemens Steinbock, MBA, Center for Quality Improvement & Innovation (CQII), New York, NY

Unspoken Cultural Norms Influencing Quality HIV/AIDS Care for WOC Track: Racism and Race Level: Advanced Presenter: Natalie A. Solomon-Brimage, MPH, HRSA/HAB/DPD/SPNS, Rockville, MD

After this workshop, participants should be able to understand evidenceinformed interventions and data requirements to explore the preexisting systemic racism, stigma, microaggressions, and unspoken cultural norms that can influence how women of color (WOC) access, understand, and seek care. Clinicians can better tailor interventions to improve their health outcomes that address the holistic social coping mechanisms and mental health concerns that serve as both individual and structural barriers. This workshop is designed to start a dialogue to explore the rationale of why these women may appear to not be interested in receiving care and how to promote the concept of ‘securing their own oxygen masks first’ so that they can be around to care for those that depend on them.

The “Showing Up for Black Power, Liberation and Healing” Initiative Track: Racism and Race Level: Beginner Presenter: Marcus Stanley, University of Houston SUSTAIN Center, Houston, TX

Ending the HIV epidemic will require directly addressing systematic oppression and collective trauma facing communities disproportionately impacted by HIV. HIV service organizations (HSO), therefore, must be prepared to deal explicitly with racism, white supremacy and antiBlackness. It is equally essential for HSO staff to be supported in their work while navigating primary and secondary trauma; particularly Black staff who directly experience racialized trauma and often fulfill roles supporting marginalized communities. Institutional change is necessary to create organizational cultures and structures which foster transparent racial dialogue and enhance Black staff well-being. This workshop will present one such organizational change initiative- “Showing Up for Black Power, Liberation and Healing”- which was developed and implemented by Black team members of a funding and capacity building center (FCBC) working with HSOs in the U.S. South. Presenters will discuss with attendees the potential to apply this work at their own organizations.

44

2021

UNITED STATES CONFERENCE ON HIV/AIDS

In this interactive workshop, participants learn real-world strategies on how to effectively apply quality improvement (QI) methodologies to mitigate HIV disparities. Workshop attendees are introduced to the end+disparities ECHO Collaborative, the largest virtual community of practice of its kind.

From June 2018 to December 2019, 39% of all Ryan White HIV/AIDS Program recipients participated, representing over 30 states/territories, including 8 of 15 states with the lowest viral suppression rates. During the workshop, best practices are shared to promote health equity and outline improvement interventions that have measurably reduced HIV disparities. In addition, tools are shared that were used throughout this Collaborative, including the Disparities Calculator to identify measurable disparities, evidence-based/informed improvement strategies, and a video that was developed to highlight the need for improvement. The necessary steps will be highlighted to successfully plan and implement a virtual QI collaborative based on a best practice guide that was developed after the Collaborative.

PrEP4Teens: Empowering Youth to Create Their Own Social PrEP Marketing Track: Biomedical HIV Prevention Level: Beginner Presenters: Silvia Valadez-Tapia, AIDS Foundation Chicago, Chicago, IL Jim Pickett, AIDS Foundation Chicago, Chicago, IL

Teens deserve developmentally and culturally appropriate social marketing campaigns that speak to them directly. Young people make up a substantial number of new HIV diagnoses every year, with sexual and gender minority (SGM) youth bearing the brunt. Yet, there are little to no PrEP social marketing campaigns specifically designed for SGM teens, possibly contributing to the subpar PrEP uptake in this population.

Workshop facilitators will describe a community-led, interdisciplinary, and collaborative project in Cook County, IL where teens were empowered to create their own social marketing campaigns about PrEP. Drafts of the teens’ work and activation plans will be shared. Participants will practice components of this teen-led approach and engage in a creative rapid planning exercise, spotlighting their own jurisdictions’ needs on how to empower youth to create their own HIV prevention social marketing campaigns.

SESSION 2 WORKSHOPS

FRIDAY

DEC

3

Trauma Informed Management: Strategies for Supporting a Weary Workforce

Lessons learned: Implementing the TWIST intervention as a retreat

Track: Addressing issues around COVID Level: Intermediate Presenter(s):

Track: Prioritizing People Living with HIV Level: Intermediate Presenter:

Dafina M. Ward, JD, Southern AIDS Coalition, Bluffton, SC/Southern Region

Dana Williams, The Community Wellness Project, St. Louis, MO

Gina Brown, RSW, Southern AIDS Coalition, New Orleans, LA/Southern Region

Transgender women’s HIV infection rates remain elevated when compared with other populations affected by HIV. Addressing their HIV prevention needs must occur within the context of social support, gender affirmation and a transgender-specific focus. The TWIST intervention includes these aspects in its design and implementation.

Samira Ali, PhD, University of Houston College of Social Work, Houston, TX/ Southern Region Neena Smith-Bankhead, Rollins School of Public Health at Emory University, Atlanta, GA/Southern Region

Now, more than ever, leaders and managers must be cognizant of the layered needs of their staff and stakeholders. The impact of COVID on the communities we serve continues to be felt—and it reverberates within the walls of our organizations. The workforce of HIV/AIDS organizations has always been composed of passionate and committed individuals, often with a deep personal connection to their organizations’ missions.

This lived experience is what makes the work so impactful after all. The uncertainty and fear stemming from the COVID pandemic, has revealed the complexity of managing trauma, stress, and anxiety experienced by those providing services. This session will address how organizations can adopt a trauma-informed approach that extends beyond service delivery, but also to organizational policies and practices.

Healing Together, an adaptation of Common Threads©: Combating HIV-Related Stigma and Improving ART Adherence Track: Trauma-Informed Care Level: Intermediate Presenters: Helen Zimba, AIDS HealthCare Foundation, Dallas, TX

Healing Together is a project designed to create a safe space for Women Living with HIV (WLH) to gather with other women from all walks of life and discuss all the nuances of living with HIV. This space serves to educate women about the contributing factors that made them vulnerable to contracting the virus, create community for women to share their lived experiences managing their diagnoses and comorbidities, and identify a path forward as they embrace the reality that they are not defined by their status. In an interactive and informal setting, participants will break out into smaller groups with assigned facilitators to participate in learning activities and exercises aimed at selfcare through the acceptance and celebration of everything we are, including but not limited to, Women Living with HIV.

#2021USCHA

45

DEC

3

FRIDAY

PLENARY & EXHIBIT HALL

12:00 PM - 1:00 PM EST Plenary

Voices of Resilience: Forging Progress and Urgency in Challenging Times Presented by Gilead

Please join Gilead Sciences for our USCHA plenary, titled, Voices of Resilience: Forging Progress and Urgency in Challenging Times.

Moderated by Tori Cooper, the program will feature grassroots advocates working in the Southern U.S. to address barriers to helping end the HIV epidemic, particularly in response to the COVID-19 pandemic. A panel discussion will explore how these advocates are helping forge progress, through innovation and resilience in challenging times.

Morrison

Schmid

Carcaño

Walker

Gore

Jones

McKensey

Romero

1:00 pm - 2:00 pm H : ost

Tori Cooper, Director of Community Engagement for the Transgender Justice Initiative, Human Rights Campaign Presenters: Tony Morrison, Senior Producer, Good Morning America Digital Karl Schmid, Broadcaster and Executive Producer, Plus Life Media Joaquín Carcaño, Director of Community Organizing, Latino Commission on AIDS, Latinos in the South Program Tony Christon-Walker, Director of Prevention and Community Partnerships, AIDS Alabama Kayla Gore, Founder, Tiny House Project, Executive Director, My Sistah’s House Antoinette Jones, HIV Peer Specialist and Advocate, SisterLove, Inc. Zakia McKensey, Executive Director and Founder, Nationz Foundation José Romero, HIV Racial & Language Justice Consultant and Founder, A Pozitive Approach

12:00 pm - 5:00 pm Lounges

Lounges Open

1:00 PM - 5:00 PM EST Exhibitions

Virtual Exhibit Hall Open

46

2021

UNITED STATES CONFERENCE ON HIV/AIDS

SESSION 3 WORKSHOPS

FRIDAY

DEC

3

1:15 PM - 2:15 PM EST Session 3 Workshops

The Importance of Testing and Care in Helping End the HIV Epidemic

initiatives. Attendees will leave with educational resources and a communication toolkit to start delivering messaging that promotes love, acceptance and healing in the context of HIV and faith.

Presented by Gilead

Gilead Sciences, Inc. is hosting an interactive workshop on the importance of HIV testing and care in helping end the HIV epidemic. In this workshop, participants will explore the central role of HIV testing to the status-neutral HIV care continuum in line with the National HIV Strategy and review treatment and prevention options. In addition, attendees will reflect on knowing ones’ vulnerability to HIV and addressing stigma, the importance of cultural humility as a path to equity and patient-centered care. Small group, facilitated discussions will allow participants to engage with the presenters, network with each other, and share best practices.

Making the HOPWA Program Work for Your Community Pathway: Housing Presenter(s): Lauren Banks Killelea, Director of Policy & Advocacy, National AIDS Housing Coalition, Washington, DC Ernest Hopkins, Senior Strategist & Advisor, San Francisco AIDS Foundation, San Francisco, CA Pete Toepfer, Senior Vice President of Housing, AIDS Foundation of Chicago, Chicago, IL

Blessings and Barriers: Using storytelling to challenge traditional narratives about HIV, sexuality and faith Pathway: Faith Curated by the Gilead COMPASS Faith Coordinating Center, Wake Forest University School of Divinity Dr. Allison Mathews, Executive Director, COMPASS Faith Coordinating Center, Wake Forest University Dr. Shonda Jones, Principal Investigator, COMPASS Faith Coordinating Center, Associate Dean, Wake Forest University, Sande Bailey, Executive Director, Foundations for Living Dr. Ulysses Burley III, Founder, UBtheCURE, LLC Elder Carmarion D. Anderson-Harvey, Alabama State Director, Human Rights Campaign

The HIV/AIDS epidemic in the South is of particular concern given rising case numbers and the disproportionate impact of the epidemic on African American community members. According to the Centers for Disease Control and Prevention (CDC), the South is more affected by HIV/AIDS than any other region of the US and accounts for 54% of all new HIV diagnoses in the US. Further, though southern states comprise approximately one third of the overall population in the US, they account for nearly 44% of all people living with HIV in the US. How can religious leaders and faith communities imagine and give voice to a healing and life-producing narrative and thus systemic shift? Religious leaders and faith communities have a unique opportunity to change the HIV/AIDS narrative and landscape in the South. Our workshop focuses on activating faith communities and their leaders to embody this redemptive and transformative work.

Attendees will gain skills to more effectively communicate about HIV and sexuality through storytelling in faith communities, develop strategic plans to establish and expand faith-based initiatives, integrate liberation theology into sermons and faith community programming, and establish and strengthen community-academic partnerships to create sustainable

This workshop will focus on strengthening current HOPWA grantees and subgrantees by advocating for best practices that will serve your community. This is a workshop intended for community advocates and people living with HIV/AIDS. Learn how to find out program data for the HOPWA grantee in your area and how to use that information to leverage better outcomes. We will discuss ways to advocate at the local level to ensure the HOPWA program is engaging in best practices to better serve the community need.

Trends in HIV Diagnoses, Care and Viral Suppression Among Hispanic/Latinx and Challenges in Addressing the HIV Epidemic Among Hispanic/Latinx in the Deep South.

Pathway: CDC Presenters: Sonia Singh, PhD MHS, Epidemiologist, CDC/NCHHSTP/DHP, Atlanta, GA Joaquín Carcaño, Director of Community Organizing Latinos in the South, Latino Commission on AIDS, New York, NY

Presentation will address the fact that Hispanic/Latinx are disproportionately affected by HIV. In 2019, Hispanic/Latinx accounted for 18% of the U.S. population, but 28% of HIV diagnoses, and reported the second highest incidence rate among races/ethnicities (21.7 per 100,000) in the U.S. National HIV Surveillance System data was used to examine HIV diagnosis, linkage to care and viral suppression by age, sex, transmission categories to help elucidate which subgroups could benefit from increased HIV testing and improvement in HIV care outcomes. It will also provide an update on Hispanic/Latinx community efforts to advance EHE in the Deep South of the United States. The presentation aims to promote dialogue and discussion on strategies at the city, county and state levels to promote ending the HIV epidemic. The presenter will highlight the impact of HIV, viral hepatitis and STIs in the south and challenges related to the impact of COVID-19.

#2021USCHA

47

with DESCOVY for PrEP® DESCOVY for PrEP (pre-exposure prophylaxis) is a once-daily prescription medicine for adults and adolescents at risk of HIV. It helps lower the chances of getting HIV through sex.

DESCOVY for PrEP is not for everyone: • It is not for use in people assigned female at birth who are at risk of getting HIV from vaginal sex, because its effectiveness has not been studied.

• You must be HIV-negative before and while taking DESCOVY for PrEP. Ask a healthcare provider if DESCOVY for PrEP is right for you.

To learn more, visit AboutDescovy.com.

IMPORTANT FACTS ABOUT DESCOVY (des-KOH-vee) This is only a brief summary of important information about taking DESCOVY for PrEP (pre-exposure prophylaxis). This does not replace talking to your healthcare provider about your medicine.

MOST IMPORTANT INFORMATION ABOUT DESCOVY FOR PrEP

Before starting and while taking DESCOVY for PrEP: • You must be HIV-negative. You must get tested for HIV immediately before and at least every 3 months while taking DESCOVY. If you think you were exposed to HIV, tell your healthcare provider right away. They may want to do more tests to confirm that you are still HIV-negative.

• Many HIV tests can miss HIV infection in a person who has recently become infected. Symptoms of new HIV infection include tiredness, fever, joint or muscle aches, headache, sore throat, vomiting, diarrhea, rash, night sweats, and/or enlarged lymph nodes in the neck or groin. Tell your healthcare provider if you have had a flu-like illness within the last month before starting or while taking DESCOVY. • DESCOVY does not prevent other sexually transmitted infections (STIs). Practice safer sex by using a latex or polyurethane condom to reduce the risk of getting STIs. • DESCOVY by itself is not a complete treatment for HIV-1. Do not take DESCOVY for PrEP unless you are confirmed to be HIV negative.

DESCOVY may cause serious side effects, including: • Worsening of hepatitis B (HBV) infection. Your healthcare provider will test you for HBV. If you

have HBV and stop taking DESCOVY, your HBV may suddenly get worse. Do not stop taking DESCOVY without first talking to your healthcare provider, as they will need to check or give you HBV medicine.

ABOUT DESCOVY FOR PrEP

DESCOVY for PrEP is a once-daily prescription medicine for adults and adolescents at risk of HIV who weigh at least 77 pounds. It helps lower the chances of getting HIV through sex.

DESCOVY for PrEP is not for everyone: • It is not for use in people assigned female at birth who are at risk of getting HIV from vaginal sex, because its effectiveness has not been studied.

• You must be HIV-negative before and while taking DESCOVY for PrEP. To help determine your risk of getting HIV-1, talk openly with your healthcare provider about your sexual health.

Do NOT take DESCOVY for PrEP if you: • Already have HIV infection or if you do not know your HIV status. If you have HIV-1, you need more medicine than DESCOVY alone to treat HIV-1.

If you have HIV-1 and take only DESCOVY, your HIV-1 may become harder to treat now and in the future.

Eligible patients may pay as little as a $0 co-pay.*

Actor portrayals

DESCOVY® is the smallest pill approved for PrEP. Actual size: 13mm x 6mm

POSSIBLE SIDE EFFECTS OF DESCOVY FOR PrEP

DESCOVY can cause serious side effects, including: • Those in the “Most Important Information About DESCOVY for PrEP” section.

• New or worse kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys before and during treatment with DESCOVY. If you develop kidney problems, your healthcare provider may tell you to stop taking DESCOVY. • Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat.

• Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark

“tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain.

Common side effects in people taking DESCOVY for PrEP include diarrhea, nausea, headache, fatigue, and stomach pain.

These are not all the possible side effects of DESCOVY. Tell your healthcare provider right away if you have any new symptoms while taking DESCOVY for PrEP. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch, or call 1-800-FDA-1088.

Your healthcare provider will need to do tests to monitor your health before and during treatment with DESCOVY for PrEP. See next page for more IMPORTANT FACTS ABOUT DESCOVY. *Advancing Access® co-pay coupon support is available for commercially insured eligible patients only. Restrictions apply. Subject to change; for full terms and conditions, visit GileadAdvancingAccess.com.

It’s time.

Ask a healthcare provider if DESCOVY for PrEP® is right for you.

Get more information at AboutDescovy.com IMPORTANT FACTS ABOUT DESCOVY (cont’d) BEFORE TAKING DESCOVY FOR PrEP

Tell your healthcare provider if you: • Have or have had any kidney or liver problems, including hepatitis.

• Have any other medical conditions.

Tell your healthcare provider about all the medicines you take: • Keep a list that includes all prescription and over-the-counter medicines, vitamins, and herbal supplements, and show it to your healthcare provider and pharmacist.

• Ask your healthcare provider or pharmacist about medicines that should not be taken with DESCOVY for PrEP. HOW TO TAKE DESCOVY FOR PrEP

• Take 1 tablet once a day, every day, not just when you think you have been exposed to HIV-1.

• Do not miss any doses. Missing doses may increase your risk of getting HIV-1 infection.

• Get tested for HIV-1 at least every 3 months.

You must stay HIV-negative to keep taking DESCOVY for PrEP.

HOW TO FURTHER REDUCE YOUR RISK

• Know your HIV status and the HIV status of your partners. If your partner is living with HIV, your risk of getting HIV is lower if your partner consistently takes HIV treatment every day.

• Get tested for other STIs. Some STIs make it easier for HIV to infect you.

• Practice safer sex by using latex or polyurethane condoms.

• Talk to your healthcare provider about all the ways to help reduce HIV risk.

GET MORE INFORMATION

• This is only a brief summary of important information about DESCOVY for PrEP. Talk to your healthcare provider or pharmacist to learn more.

• Go to DESCOVY.com/prep or call 1-800-GILEAD-5 • If you need help paying for your medicine, visit DESCOVY.com/prep for program information.

DESCOVY FOR PrEP, the DESCOVY FOR PrEP Logo, the DESCOVY Blue Pill Design, DESCOVY, the DESCOVY Logo, STEP UP. PrEP UP., ADVANCING ACCESS, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc., or its related companies. ©2020 Gilead Sciences, Inc. All rights reserved. DVYC0331 10/20

DEC

3

FRIDAY

Harm Reduction (More Than Just Syringe Exchange) Pathway: Hepatitis Level: Intermediate Presenters: Tasha Turner-Bicknell, University of Cincinnati, Cincinnati, OH Judith Leahy and Samantha Byers, Oregon Health Authority, Salem, OR Eman Addish, Philadelphia Department of Public Health, Philadelphia, PA Michelle Mathis and Timothy Nolan, Olive Branch Ministry, Hickory, NC

Hepatitis elimination will not be possible unless the communities most disparately impacted have access to the services, tools, and programs that prevent new cases from occurring, link existing cases to treatment, and ensure individuals are informed and ready to participate. Lack of access to sterile syringes is a key driver of new hepatitis cases in the country, and something that absolutely needs to be addressed as we work toward elimination. But syringe exchange is not the only form of harm reduction, and not the only intersection of hepatitis and harm reduction services.

In this workshop, presenters will provide their first-hand experience and lessons learned from running harm reduction programs that reduce or prevent viral hepatitis through innovative approaches like safer smoking kits, peer-to-peer navigation, co-locating hepatitis and substance-use treatments services, and building syringe access programs in faith-based settings.

Challenges and Innovations in Rural Sexual Health Pathway: STIs Pathway hosted by National Coalition of STD Directors Presenters: Jenny Mahn, National Coalition of STD Directors, Washington, DC Michael Canty, National Coalition of STD Directors, Washington, DC

In this workshop, we will explore the unique challenges and barriers that sexual health service providers in rural areas contend with including PrEP provision and retention, routine STI screening, and partner services. We will then highlight innovations from around the country that address these challenges and then break out into small groups to troubleshoot related challenges you are experiencing in your service area. You will leave this session armed with new ideas and empowered to improve sexual health services in your jurisdiction!

Rapid ART Start: Improving HIV Engagement and Care Pathway: HRSA Level: Intermediate Presenter: Tamika Martin, HRSA, Rockville MD

Immediate antiretroviral therapy (Rapid ART Start) refers to starting treatment as soon as possible after diagnosis of HIV. EHE jurisdictions

52

2021

UNITED STATES CONFERENCE ON HIV/AIDS

SESSION 3 WORKSHOPS

funded by HRSA HAB focus on linking people with HIV who are either newly diagnosed or diagnosed but not in care, to essential HIV care and treatment and to support services so they reach an undetectable viral load quickly and stop transmission. Of the 47 EHE jurisdictions, 40% are implementing Rapid ART Start strategies to accelerate the time from new diagnosis to entry into care and initiation of ART treatment and to improve retention in care and sustained viral suppression. HAB EHE technical assistance and system coordination providers assist jurisdictions in the implementation of Rapid ART Start and other innovations to end the HIV epidemic. This presentation will highlight the successes and lessons learned among HAB EHE recipients in the jurisdictions who are implementing Rapid ART Start strategies.

Innovative Responses in Nutrition for People Living with HIV Pathway: Structural Interventions Presenters: Thomas Pietrogallo, CEO, The Poverello Center, Wilton Manors, FL Brandi Sasore, Communications Manager, Partners in Nutrition Indiana, Indianapolis, IN Will Thomas, Director, Government Relations and Public Funding, Food & Friends, Washington, DC

Across the country, providers of support services for PLWH have stepped into the gap to deliver during the COVID-19 pandemic. The need for nutrition emerged as a foundational gap in our country’s safety net.

From pre-pandemic through the surge, join this session to understand how three providers in different states have been putting the nutrition needs of PLWH front and center. The Poverello Center in FL will present on Implementing Evidence-Informed Interventions (E2i) to improve HIV care – a SPNS project - in the non-traditional setting of a food pantry in FL. Partners in Nutrition Indiana will showcase their statewide medically tailored meal program and their outsized response during the pandemic.

Finally, Food & Friends in Washington, DC will discuss various policy levers available to highlight the needs of PLWH and a specific project they championed locally in DC. Implications for national policy will be discussed as we move toward Ending the HIV Epidemic in the midst of a pandemic.

Trauma-Informed Leadership and Supervision: A Time to Rethink Leadership Track: Trauma-Informed Care Level: Intermediate Presenter(s): Lladira Aguilar, University of Houston, Houston, TX

The socio-political context of the US has become increasingly distressing and precarious due to recent and recurring events (i.e., the COVID-19 pandemic, police brutality). These unprecedented events highlight the ways in which intersecting systemic oppressions (i.e. anti-Black racism, sexism, heterosexism, etc.) continue to perpetuate trauma among communities including those impacted by HIV/AIDS. This oppressive context, in combination with organizational factors, such as minimal

SESSION 3 WORKSHOPS

resources, under-staffed organizations and cumbersome caseloads are barriers to staff in providing quality care to people living with HIV. This can result in burnout, secondary trauma, high turnover, compassion fatigue and overall dissatisfaction among staff. To end the HIV epidemic, we must consider the negative impact of systemic trauma, social unrest, and organizational environments on both staff and clients. Now more than ever before, Trauma-informed Leadership and Supervision is an imperative strategy to re-think leadership and build equitable and trauma-informed environments.

Advocating for Increasingly Aggressive Management of HIV/HCV Co-infection in PWID Track: Treatment and Research Level: Intermediate Presenter: Yussef Bennani, MD, MPH, Louisiana State University Health Sciences Center New Orleans, New Orleans, LA

In past years, people with HIV (PWH) co-infected with hepatitis C virus (HCV) were collectively undertreated given side effects of HCV therapies, less favorable HCV treatment outcomes in PWH and complex drugdrug interactions between HIV and HCV drugs. However, even with the emergence of direct-acting antiviral (DAA) therapy for HCV, this population continues to have decreased access to HCV therapy. This workshop will review epidemiology of HIV and HCV co-infection and review the greater urgency to treat HCV in this population. Furthermore, it will discuss provider misconceptions about treating co-infected patients actively injecting drugs and review the growing body of evidence suggesting high cure rates and low re-infection rates in this sub-population. We will review suggested multidisciplinary approaches to managing co-infected patients, the potential public health benefits, as well as discuss advocating for policy change among insurance programs currently precluding HCV therapy in patients actively injecting drugs.

Interrupting Stigma where HIV & Opioid Use Disorder Intersect Track: Prioritizing People Living with HIV Level: Intermediate Presenters: Hannabah Blue (Diné), MSPH, JSI Research & Training Institute, Inc., Denver, CO Arman Lorz, BS, JSI Research & Training Institute, Inc., Denver, CO

This workshop will focus on how stigma relating to HIV and Opioid Use Disorder manifests and affects diverse communities. Participants will learn about the pathways of stigma from the drivers and types to how it manifests in health systems, and then how it affects individuals and communities. Participants will engage in interactive discussions and activities that will provide examples of opportunities for interrupting stigma at the individual, interpersonal, organizational and systems levels.

Facilitators will share the Interrupting Stigma: A Conceptual Map Depicting Stigma Pathways & Intervening Strategies at the Intersection of HIV &

FRIDAY

DEC

3

Opioid Use Disorder (OUD) as a handout, which describes the pathways of stigma at the intersection of HIV and OUD systems, and introduces opportunities for multi-level intervening strategies

The Benefits of Telehealth Extend Beyond the Pandemic Track: Best Practices in TeleHealth Level: Intermediate Presenters: Leslie Cockerham, MD, Vivent Health, Milwaukee, WI April Johnsen, RN, Vivent Health, Milwaukee, WI Hailey Keeser, PharmD, AAHIVP, Vivent Health, Milwaukee, WI Crystal McLean, MA, LPC, Vivent Health, Milwaukee, WI

The COVID-19 pandemic necessitated a dramatic change in the delivery of care and treatment. Previously, telehealth was available at Vivent Health for psychiatry services, but we quickly expanded our virtual platforms to include psychotherapy, routine HIV care, and treatment of chronic health conditions such as diabetes and cardiovascular disease that put people at the highest risk for adverse events with COVID-19. Home monitoring devices such as blood pressure machines and glucometers allowed for the continued management of chronic diseases. As conditions with the pandemic have improved, telehealth is still being utilized to improve HIV retention to care, ART adherence and follow up of chronic health conditions with more frequent titration of medications and ongoing support. The use of telehealth has led to improved outcomes for some patients by removing barriers to care such as transportation, job schedules and childcare needs.

Internalized HIV-related Stigma in Women of Color Obtaining HIV Care Track: Treatment and Research Level: Intermediate Presenter: Mariam Davtyan, PhD, MPH, University of Southern California, Keck School of Medicine, Department of Pediatrics, Los Angeles, CA

HIV has been considered a chronic but treatable condition for more than two decades. The advent of antiretroviral medications (ARTs) has extended the life expectancy of people living with HIV (PLWH) and thus fewer people are progressing to and dying of AIDS. Despite these milestones, PLWH continue to experience HIV-related stigma. Stigma is a formidable barrier known to interfere with HIV treatment engagement, ART adherence, and viral suppression. Gender and ethnic minorities are disproportionately represented in experiences of HIV-related stigma, including internalized HIV-related stigma. In this study, we examined internalized HIV-related stigma and clinical outcomes among women of color living with HIV (WoCLWH) obtaining care at an HIV specialty center in Los Angeles County, California. Our aims were to estimate the prevalence of internalized HIVrelated stigma and to evaluate the impact of internalized stigma on ART adherence, HIV RNA viremia, and retention in care.

#2021USCHA

53

DEC

3

FRIDAY

SESSION 3 WORKSHOPS

Respuesta Comunitaria al COVID-19 en Latinx en los Estados Unidos

From the Polls to Policy: Centering Community in HIV/LGBTQIA+ Advocacy

Track: Track en español Level: Intermediate Presenter:

Track: Public Policy Level: Intermediate Presenter:

Pedro Goicochea, Legacy Project | Office of HIV/AIDS Network Coordination - HANC, Seattle, WA

Timothy Jackson, AIDS Foundation Chicago, Chicago, IL

El Latinx Caucus, un grupo de trabajo de Legacy Project de la Office of HIV/ AIDS Network Coordination (HANC), tiene como finalidad crear conciencia e incrementar la representatividad y participación de latinas y latinos en la investigación clínica en VIH, ITS, TB y COVID-19.

La comunidad latina en los Estados Unidos es la segunda comunidad más afectada por la epidemia del COVID-19. De todos los casos de COVID-19 reportados, 28.8% corresponden a este grupo, después de los blancos, 50% (CDC, 6-21-2021). Asimismo, las tasas de vacunación en esta comunidad continúan siendo bajos (15%), pero mejorando; en los últimos 14 días, 3/10 vacunas fueron administradas a latinos y latinas (KFF, 6-162021).

Este taller interactivo busca generar un espacio de discusión acerca del impacto de la epidemia del COVID-19 en la comunidad latina; identificar los factores que contribuyen a esta situación y proponer alternativas viables para reducir su efecto en la comunidad.

As we continue our efforts towards ending the HIV epidemic, it’s important that HIV and LGBTQIA+ advocacy be centered and led by the communities most impacted. The principle of Meaningful Involvement of People Living with HIV/AIDS (MIPA) is an important set of values that demands that people living with HIV be substantively engaged in policy and programmatic decision-making activities that impact our lives, While progress has been made in efforts to ending the HIV epidemic, we will not reach our desired goal until we center the communities most impacted through meaningful engagement commit to true racial health equity while addressing the social determinants of health through public policy.

Recruiting & Retaining Men of Color for Remote PrEP Project Track: Ending the HIV Epidemic (EHE) - Next Steps Level: Beginner Presenters: William Kenny, APNH: A Place to Nourish your Health, New Haven, CT

Latinx Transgender Voices to inform HIV Care and Prevention Services Track: Ending the HIV Epidemic (EHE) - Next Steps Level: Beginner Presenters: Matilde Gonzalez-Flores, MPH, CHES, Orange County Health Care Agency, Santa Ana, CA Khloe Rios-Wyatt, Alianza Translatinx, Santa Ana, CA

As part Orange County’s Ending the HIV Epidemic Initiative community engagement efforts, a new partnership was formed between the local public health department (Orange County Health Care Agency) and Alianza Translatinx, the first transgender-led organization by transgender people of color in the county. This interactive workshop will provide an overview of the community engagement process for developing new partnerships with organizations that serve populations that are disproportionately impacted

by HIV and STDs and that have been historically underrepresented in the HIV planning process. Participants will hear the perspectives from both Alianza Translatinx and health department staff on best practices and approaches for meaningful engagement that are community driven.

The workshop will also provide an overview of PrEP education and needs assessment activities implemented, such as surveys and focus groups to inform the delivery of HIV care and prevention services and outcomes resulting from the partnership.

54

2021

UNITED STATES CONFERENCE ON HIV/AIDS

Daniel Davidson, CIRA at Yale University, New Haven, CT Claude Louis, Chat4Change, New Haven, CT

PrEP uptake continues to be modest among Young Black and Latinx men who have sex with men (YBLMSM). How do we engage YBLMSM when developing PrEP services and interventions? How can we prioritize YBLMSM’s experience? Go where they are. Make it worth their time.

Chat4Change is a CDC/Connecticut DPH PrEP demonstration project that recruited ~20 YBLMSM to participate in intervention development workshops and then as PrEP Ambassadors, engaging peers in conversations about PrEP on social media and location-based “dating” apps. We recruited on these platforms and held interactive Zoom sessions with a 90% retention rate. Keys to success have been logistical (text and phone call reminders) and intentional; we’ve created a space that is fun and prioritizes YBLMSM voices.

This workshop will engage participants in activities we’ve found most successful with our PrEP Ambassadors that you can use back at home to inform your outreach, recruitment, and PrEP navigation efforts.

SESSION 3 WORKSHOPS

FRIDAY

DEC

3

The Power Dynamics of MIPA in HIV Criminalization

Telehealth and HIV Self-testing: Improving your “Webside Manners!”

Track: Prioritizing People Living with HIV Level: Intermediate Presenters:

Track: Best Practices in TeleHealth Level: Intermediate Presenters:

Kamaria Laffrey, The Sero Project, Winter Haven, FL

Sarahjane Rath, Primary Care Development Corporation, New York, NY

Steven Bryson, Esq.; Sero Legal Fellow at AIDS Law Project of Pennsylvania, Pennsylvania, PA

Alwyn Cohall, MD, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY

This past year held unprecedented bursts of success in the HIV criminalization movement changing many state laws. Virginia, Nevada, and Missouri all modernized and Illinois repealed their laws through coalition and network support. All of these efforts were led by state residents living with HIV and collaborating with local and national organizations that brought invaluable resources. The response to navigating the fine line between power dynamics of lived experiences and organizational priorities did not hinder the success but highlighted the continued need for deep analysis of the impact of HIV criminalization.

Judy Lipshutz, MSW, RN, New York, NY

The UN Development Program (UNDP) released a Guidance for Prosecutors on HIV-related criminal cases which stressed criminalization as a last resort.

This workshop will highlight the different strategies state coalitions used to modernize their laws and what benefits come with compromise as well as key points to remember for drafting legislation and successful strategies to garner support of legislators.

Facilitating Posttraumatic Growth and Resilience in HIV Care Settings Track: Trauma-Informed Care Level: Intermediate Presenter: Karla McCarthy, LMSW, Coastal Family Health Center, Biloxi, MS

The syndemic nature of trauma and HIV has led healthcare facilities to adopt a “trauma-informed care” model of service delivery in order to improve healthcare outcomes and enhance patients’ quality of life.

Research consistently demonstrates that PLWHIV are more likely than the general population to have extensive trauma histories, and therefore, are more likely to suffer from chronic health conditions. This reality allows ample opportunity for posttraumatic growth, a positive change resulting from trauma, to occur. As the fields of social work and traumatology continue to identify and build upon strengths and resources instead of focusing solely on pathology, it is imperative that we, as healthcare professionals, apply what we know about PTG and resilience to our clinical practices. Participants will be engaged in activities to facilitate discussion surrounding PTG and its application in HIV care. Practical strategies to foster resilience and promote PTG will be shared and practiced.

In this interactive workshop, the Primary Care Development Corporation (PCDC) staff will provide information, skills-building activities and tools related to communication strategies when using telehealth for HIV Selftesting (HST). To set the stage, PCDC will present didactic information about telehealth, research to support its use, and a brief overview on HST. The workshop will also include experiential and interactive learning processes, including discussion groups, core skills and tools (e.g., motivational interviewing), brainstorming, and role-playing activities using case scenarios of HST telehealth sessions. The workshop will explore potential challenges and communication barriers to implement a telehealth session for HST including the use of plain language and teach-backs in explaining health information. We will also review issues specific for special populations including/ such as individuals involved with intimate partner violence and adolescents as it relates to HST. Participants will be encouraged to discuss and create a next steps plan.

Femme Noire Invisible: Uncloaking the HIV+ Cisgender Black Woman Track: Racism and Race Level: Intermediate Presenters: Dr. Tashina Reeder, LSW, Piladelphia FIGHT, Philadelphia, PA LáDeia Joyce McNeal, MBA, Orlando, FL

This year marks the fortieth anniversary of the first HIV diagnosis in the United States of America, and cisgender Black women living with HIV of AIDS are still invisible to policymakers, funders, media, and within the healthcare system. Why??? The issue of invisibility and the gross misrepresentation of cisgender Black women diagnosed with HIV continues to be an ongoing issue that is suffocating the well-being of Black women.

Using Critical Race Theory as the guiding lens for this presentation, we will offer perspective to acknowledge and unpack systemic racist influences on historical and current trends specific to this issue. A trauma-informed approach will be presented as a blueprint to correct invisibility and expose systemic barriers to inform change, improve personal awareness, and cultivate visible culturally sensitive partnerships with cisgender Black women.

#2021USCHA

55

DEC

3

FRIDAY

Pivot, Adapt and Rise: “These are the same issues…just worse” Track: Addressing issues around COVID Level: Beginner Presenters:

SESSION 3 WORKSHOPS

management must be addressed to ensure concepts related to sexual preferences, historical trauma and medical mistrust are met with empathy and respect. So how do we get there? This highly interactive workshop will provide (1) effective tools to explore the needs of Black MSM and (2) offer activities/solutions to deconstruct bias in health care and optimize patient/ client engagement.

Linda Sprague Martinez, Boston University, Boston, MA

In the fall of 2020 the Black Women First (BWF) initiative was launched to implement culturally responsive, evidence informed bundled interventions to meet the unique health needs of diverse Black women living with HIV. Funded by the Health Resources and Services Administrations (HRSA), HIV/AIDS Bureau, Special Projects of National Significance (SPNS) program, the initiative is being carried out by 12 demonstration sites in the United States. When the original grants were submitted no one could have imagined or planned for the toll coronavirus disease 2019 (COVID-19) would take on communities. Sites found themselves having to adjust their plans and rethink their approach.

Drawing on baseline implementation data and first-hand accounts from sites this session explores site adaptations, novel strategies for reaching clients and ensuring their meaningful engagement in a virtual treatment landscape. Organizational changes made to ensure staff wellbeing during this unsettling time period will also be discussed.

Understanding Black Men: Culture, Stigma, Sexuality and Getting-to-Zero Track: Racism and Race Level: Intermediate Presenter: Brian Taylor, University of Illinois at Chicago - MATEC, Chicago, IL

Many public health programs have sought to better understand the complexities associated with Black Men who have Sex with Men (MSM); however, the fundamental component that is seemingly overlooked requires the dissection of varying layers of their oppression, based on the categories they represent: (1) Black Men, (2) Black MSM, (3) HIV-positive Black MSM and (4) HIV-positive Black MSM with a criminal history. Each area of concentration requires equal attention and strategic approaches to identify and address the socio-cultural needs of each population.

Additionally, concepts related to cultural humility and emotional self-

56

2021

UNITED STATES CONFERENCE ON HIV/AIDS

Stakeholder-driven approach to improving HIV PrEP awareness among university students Track: Biomedical HIV Prevention Level: Beginner Presenters: Kenric Ware, PharmD, South University, Columbia, SC Russell Campbell, MA, HIV/AIDS Network Coordination, Seattle, WA Lance Okeke, MD, Duke University, Durham, NC

HIV pre-exposure prophylaxis (PrEP) is a proven and effective HIV prevention strategy. Despite its effectiveness, awareness among young adults (age 18-29) remains suboptimal. Approaches to improve young adults’ awareness of PrEP informed chiefly by their ingenuities may aid in crafting consumer-centered messaging. The Legacy Project, housed within the Office of HIV/AIDS Network Coordination, developed an online training curriculum to primarily educate young adults on HIV prevention - Be the Generation to End the AIDS Epidemic (BTG). However, for such resources to maximally impact intended populations, stakeholder involvement is required to tailor interventions to specific needs. Highlighting the BTG curriculum, human-centered design (HCD) consultation groups were conducted at South University in Columbia, SC to customize strategies to increase PrEP awareness. Drawing upon the HCD consultation group experience, this interactive workshop will highlight how student feedback can bolster the creation of locally-informed initiatives to disseminate HIV prevention information on college campuses.

FRIDAY

SESSION 4 WORKSHOPS

DEC

3

2:30 PM - 3:30 PM EST Session 4 Workshops

National Institutes of Health, Office of AIDS Research: Listening Session with OAR Director Dr. Maureen Goodenow Moderated by Paul Kawata, NMAC, Washington, DC Introduction by Dr. Maureen Goodenow, Office of AIDS Research (OAR), Rockville, MD

The Office of AIDS Research (OAR) of the National Institutes of Health (NIH) is charged with coordinating the scientific, budgetary, and policy elements of NIH’s comprehensive HIV/AIDS research program across the Institutes, Centers, and Offices (ICO) of the NIH. To fulfill its charge, and to ensure that the overall NIH HIV/AIDS research program and priorities are responsive to emerging scientific advances, changes in the epidemic and the contexts in which it is occurring, and the needs of diverse communities, OAR regularly obtains input from multiple stakeholders through Listening Sessions.

There are many funding streams that support housing for persons living with HIV/AIDS. Learn about the federal funding portfolio, including HOPWA and other HUD programs that can be used to house PLWHA. The Ryan White program is increasingly being used for housing and even Medicaid can be used for housing in a few states. This session will give an overview of how to use various funding sources to create housing for PLWHA as well as the limitations and advantages of each program.

Coalition Building for Sustained Response Pathway: Hepatitis Level: Intermediate Presenters: Emily Killian, Catawba County Hepatitis Coalition, Newton, NC Marcus J. Hopkins, Community Education Group, WV A. Toni Young, Community Education Group, WV Catherine Freeland, Hepatitis B Foundation, Doylestown, PA

Nothing Left Unsaid: Keeping it 100 with Your Care Team Presented by Janssen Therapeutics

Join the Positively Fearless ambassadors for a real-talk discussion as they wrestle with longstanding gaps in the conversations between patients and their care team. Whether we’re talking about sexual history, gender identity, or treatment side effects like body changes – we can all agree some topics can be uncomfortable to bring up with your doctor, making it difficult to feel heard and challenging to paint the full picture of your lifestyle and healthcare needs for your care team. In this 45-minute conversation, Mychelle Williams, LPC (aka the Black Queer Black Therapist) will lead the ambassadors through a workshop focused on how to navigate through fear and stigma and how to get the most out of conversations with your doctor about your health routine and treatment plan. HIV specialist, Dr. David Malebranche, will also be on hand to lend valuable insights from a physician’s perspective to the conversation.

Funding Housing: HOPWA, Ryan White, and More Pathway: Housing Level: Intermediate

Christina Caputo, North Carolina Department of Health and Human Services, Raleigh, NC

So you want to end viral hepatitis in your city/county/state/nation? GREAT! But what’s the first step? This presentation will look at specific local, county, and state efforts to combat viral hepatitis, and how leveraging a collaborative coalition approach can be a model for success when designing and implementing hepatitis elimination plans and other hepatitis programs. While this workshop will be fairly hepatitis-specific, strategies discussed are applicable for those interested in other grassroots, policy, and infectious disease coalition building.

Adolescent Sexual Health and HIV/STD Telemedicine Services During the COVID-19 Pandemic Pathway: STIs Pathway hosted by National Coalition of STD Directors Level: Intermediate Presenters: Jerrica Davis, National Coalition of STD Directors, Washington, DC Desiree Smith, National Coalition of STD Directors, Washington, DC Christy Altidor, National Coalition of STD Directors, Washington, DC

Presenters:

Jenny Mahn, National Coalition of STD Directors, Washington, DC

John Rojas, Deputy Chief Special Services Officer, NYC Department of Social Services, New York, NY

Michael Canty, National Coalition of STD Directors, Washington, DC

Traswell Livingston, CEO, AIDS Dallas, Dallas, TX Kathie Hiers, CEO, AIDS Alabama, Birmingham, AL

As the COVID-19 pandemic persists, adolescents across the nation are either virtually learning or attending school in person at reduced capacity.

Telemedicine, in exchange for in-person visits, has proven to be a valid

#2021USCHA

57

DEC

3

FRIDAY

and reasonable form of care during this current pandemic. This interactive workshop will discuss telehealth and telemedicine best practices and models to provide attendees with tools and guidance to respond to COVID-19 related needs and provide HIV/STD prevention for adolescents.

Activities include collaborative strategy sharing amongst attendees and integrating provider input to identify opportunities for improving telemedicine services.

Community Engagement: Leading change to end the HIV epidemic in the midst of COVID 19 Pathway: HRSA Presenters: Antigone Dempsey, HRSA HAB, Rockville, MD Yemisi Odusanya, HRSA HAB, Rockville, MD

Community engagement has long been a cornerstone of the Ryan White HIV/AIDS Program (RWHAP) and it continues to be a vital part of the Ending the HIV Epidemic in the U.S. (EHE) initiative. HRSA HAB EHE jurisdictions are including the voices of people with HIV, their communities, and stakeholders in the planning, implementation, and evaluation of prevention, care, treatment, and support services. HRSA HAB will also share newly developed tools and strategies to further support community engagement as a key strategy for ending HIV.

HIV Status Neutral: Paradigm shift for the HIV prevention and care cycle Pathway: CDC Level: Advanced Presenters: Benjamin Tsoi, MD, MPH, Director of HIV Prevention, Bureau of Hepatitis, HIV, and Sexually Transmitted Infections, New York City Health Department, New York, NY Clover L. Barnes, MBA, BSN, RN, Chief, Care and Treatment Division, DC Department of Health, Washington, DC Dave Kern, Deputy Commissioner, HIV/STI Bureau, Chicago Department of Health, Chicago, IL

Recent biomedical advances provide us new tools to assist in our efforts to end the HIV epidemic. Applying these advances with a status-neutral approach to HIV care means that all people, regardless of HIV status, are engaged in the same way. Embracing new approaches for treatment and prevention is a priority to accelerate progress in reaching national goals.

During this session, New York City, Chicago, and District of Columbia departments of health will share with participants their experience designing and implementing the HIV Status Neutral approach in their jurisdictions. Presenters will discuss how this approach fits, complements, or enhances existing approaches that can lead to an undetectable viral load and an effective HIV prevention.

58

2021

UNITED STATES CONFERENCE ON HIV/AIDS

SESSION 4 WORKSHOPS

Social marketing campaign for HIV self-testing during COVID-19 and beyond Track: Ending the HIV Epidemic (EHE) - Next Steps Level: Intermediate Presenters: Euna M. August, PhD, MPH, MCHES, Centers for Disease Control & Prevention, Atlanta, GA Emily A. Lilo, PhD, MPH, Centers for Disease Control & Prevention, Atlanta, GA Christopher Voegeli, PhD, MPH, Centers for Disease Control & Prevention, Atlanta, GA Revae S. Downey, MPH, CHES, Centers for Disease Control & Prevention, Atlanta, GA Jennie Johnston Gayden, Centers for Disease Control & Prevention, Atlanta, GA Brian Emerson, Centers for Disease Control & Prevention, Atlanta, GA Jen Hecht, MPH, Centers for Disease Control & Prevention, Atlanta, GA Pollyanna Chavez, PhD, Centers for Disease Control & Prevention, Atlanta, GA Emily Pingel, PhD, MPH, Centers for Disease Control & Prevention, Atlanta, GA Kevin Delaney, PhD, Centers for Disease Control & Prevention, Atlanta, GA

In February 2021, the Centers for Disease Control and Prevention (CDC) and partners launched a national demonstration project to promote the use of HIV self-tests as part of the Ending the HIV Epidemic in the US (EHE) initiative. We used a social marketing approach in EHE priority jurisdictions to encourage people to order free HIV self-tests. Gay men (particularly African American and Latino men), African American women, and transgender women were prioritized due to the disproportionate impact of HIV on these communities. Developed to expand access to HIV testing under EHE, the program also provided an important testing alternative during the COVID-19 pandemic. We will present lessons learned on messaging and media buying strategies and share how health departments can tailor this project to provide HIV self-tests in their own jurisdictions, both while the COVID-19 pandemic persists and beyond.

Successful Strategy to Engage YMSMC to Telehealth PrEP Track: Best Practices in TeleHealth Level: Beginner Presenter: Miguel Bujanda, REACH LA, Los Angeles, CA

The most significant prevention strategy to achieve Ending the HIV Epidemic in the US is PrEP (99% protection). Appropriate implementation of PrEP to achieve EHE goals requires working with high-risk communities.

This presentation will provide an innovative approach to address

SESSION 4 WORKSHOPS

disparities in accessing PrEP in hard-to-reach communities, such as young MSM of color. Several barriers to access and acceptability for PrEP include poor transportation, constrained scheduling availability, stigma, mistrust, and limited understanding of YMSMC culture. Recently, the effect of the COVID-19 pandemic further bolstered these barriers. Clinical settings have the capacity to prescribe PrEP, but community-based organizations have the key to community access and engagement. Why are we not working together? REACH LA piloted a project to address the gaps in accessibility to PrEP by YMSMC. This workshop will explore the results of this project, and CAI will share areas of organization and individual opportunities for capacity building.

Building Rapid-Response Surveys to Strengthen Your Organization Track: Addressing issues around COVID Level: Intermediate Presenters: Emma Creamer, Community Education Group, Washington, DC A. Toni Young, Community Education Group, Washington, DC Amanda Morgan, Community Education Group, Washington, DC Marcus Hopkins, Community Education Group, Washington, DC

FRIDAY

DEC

3

in people, voices, and imagery. Using “Indian humor” and culturally and community specific knowledge, the video includes discussions about condom use, PrEP, and HIV and STD testing. Viewers are left with a call to action to feel empowered about their sexual wellness by having open and honest conversations with their partner(s), friends/family, relatives, and healthcare providers.

Increasing PrEP Uptake: When a Clinic Feels Like a “Casita” Track: Biomedical HIV Prevention Level: Intermediate Presenters: Stephen Fallon, PhD, Latinos Salud, Wilton Manors, FL Orlando Sosa, Latinos Salud, Miami, FL

Latinos Salud, a gay, minority-based agency serving the South Florida region with the highest new HIV rates in the nation, sought to increase PrEP uptake by Latinx and other MSM of color. Between 2016 and 2018, we staged PrEP town halls and educational galas, and created social media campaigns, pamphlets and videos. PrEP awareness in our population more than doubled, but PrEP uptake did not increase as significantly amongst local Latinx and other MSM of color.

When the COVID-19 pandemic took firm hold in the United States, community-based organizations (CBOs), small clinics, and faith-based organizations were left wondering how best to maintain existing services or whether to provide new ones. Community Education Group (CEG) has formed an advocacy and information exchange network of rural health service providers systematically excluded from pandemic funding opportunities due to ineligibility based on laws and regulations. Upon learning that many organizations had neither the information nor resources to expand financial and other resources, CEG and this newly formed network fielded a rapid response needs assessment to document common problems to prioritize its work. The results of this survey are now available and are being used to guide the development of technical assistance and advocacy offerings with relevance beyond the rural context.

Beginning in 2019, we identified several access barriers to PrEP uptake.

Too often, clients were lost in the hand-off process to external PrEP providers. We hypothesized that implementing wrap-around services with an in-house prescribing clinic would reduce barriers. This workshop reviews the processes and challenges in launching the clinic, and the outcomes in PrEP uptake that resulted. We will also describe the ways that other CBOs can create similar local impacts.

From Glitz to Glam: Native STD/HIV Prevention

Jonatan Gioia, MD, University of Texas Health Science Center at Houston, Houston, TX

Track: Racism and Race Level: Intermediate Presenters: Leah Dodge (Little River Band of Ottawa Indians), MPH, Urban Indian Health Institute, Seattle, WA Elton Naswood (Navajo), National Native HIV Network, Denver, CO

With rates of both STDs and HIV rising in Native communities, there is a need for innovative and culturally attuned health education materials.

“From Glitz to Glam: Native STD/HIV Prevention” is a six-minute STD and HIV prevention video that features creative public health messaging from five fabulous Native Drag Queens. Furthering the need for the video, STD and HIV education materials often do not include Native representation

¿PrEParadx para el futuro?: Métodos innovadores para prevenir el VIH Track: Track en español Level: Intermediate Presenter:

¿Te imaginas un mundo en donde puedas elegir entre un inyectable, un implante o una pastilla como PrEP? Nuevas y excitantes estrategias y medicamentos se están desarrollando para ampliar nuestra caja de herramientas para prevenir el VIH. Es importante involucrar a nuestras comunidades para que aprendan sobre estos nuevos avances científicos.

En este taller interactivo, los participantes obtendrán información científica básica sobre nuevos medicamentos y estrategias para prevenir el VIH. Los participantes serán invitados a pensar en las futuras barreras para la implementación de estas estrategias como así también posibles soluciones para las mismas. Únete a la conversación. ¿Estas preparadx para el futuro?

#2021USCHA

59

DEC

3

FRIDAY

Adapting In-Person Interventions for Virtual Delivery Track: Addressing issues around COVID Level: Intermediate Presenter(s): Kristen MacKay, MPH, University of Rochester Center for Community Practice (UR-CCP), Rochester NY Peter McGrath, MPH, University of Rochester Center for Community Practice (UR-CCP), Rochester NY

SESSION 4 WORKSHOPS

top priorities to ensure parents living with HIV can make informed infantfeeding decisions. The format will be an interactive panel discussion featuring Consensus Statement authors and allowing time for audience Q&A.

Pharmacists and HIV Prevention: A Perfect Match!

Track: Public Policy Level: Intermediate Presenters:

Henry Ross, MSPH, University of Rochester Center for Community Practice (UR-CCP), Rochester NY

Matt Martin, NC AIDS Action Network, Raleigh, NC

During the COVID-19 pandemic many HIV prevention programs were faced with an unprecedented challenge: conduct group-level interventions (GLI) designed for in-person delivery in a virtual format. University of Rochester’s Center for Community Practice (UR-CCP), a regional technical assistance (TA) provider in the CDC’s Capacity Building Assistance Provider Network (CPN), has assisted a number of agencies to adapt in-person GLIs for virtual delivery during the pandemic. UR-CCP created several tools to guide agency staff through the adaptation process to assess and determine feasibility, fidelity, flexibility, and sustainability of virtual adaptation. In this workshop, UR-CCP will use multiple interactive methods to share their Virtual Adaptation Plan, Adaptation Checklist, Task List, and other tools with participants while also sharing best practices and “lessons learned” from doing adaptation work. Particular considerations for adapting interventions focusing on Black gay men will be included.

Lee Storrow, Community Education Group, Charleston, WV

Elevating Critical Conversations on Breastfeeding and HIV Track: Prioritizing People Living with HIV Level: Intermediate Presenters:

Dafina Ward, Southern AIDS Coalition, Bluffton, SC

Though they have been available since 2012 (prior for PEP), uptake for PreExposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) has been extremely slow, especially for the communities who need it the most. As we continue to advocate for equitable and accessible PrEP and PEP services, we have seen an increase in jurisdictions across the country (particularly in the Southern US) start to advance policy measures for increased uptake via pharmacy distributed PrEP and PEP without a prescription. Join NC AIDS Action Network and Southern AIDS Coalition staff as they discuss the current landscape of PrEP and PEP services in the South, outline current policy efforts (successful, failed, and in-the-works) around pharmacy distributed PrEP/PEP, and policy recommendations and actions happening in the South. Staff will also highlight current updates around policy change happening directly in North Carolina around pharmacist distribution of PEP without a prescription.

Arts as Resistance for Black, Latinx, & Indigenous LGBTQ+ communities

Allison Agwu, MD, ScM, Johns Hopkins, Baltimore, MD

Track: Racism and Race Level: Intermediate Presenter:

Ciarra Covin, The Well Project, Brooklyn, NY

Xelestial Moreno-Luz, REACH LA, Los Angeles, CA

Krista Martel, The Well Project, Brooklyn, NY

REACH LA transfers power into the hands of our LGBTQ+ clients of color through our foundational Four Pillars - Health and Wellness, Creative Arts, Personal Development, and Social Enterprise. Art education is utilized by the agency to combat racism, using queerstory, and presence of Black, Latinx, Indigenous queer and trans communities. This interactive workshop facilitated by Jamari Amour Balmain, a Black Gay Performing artist, and Xelestiál, a Latinx transgender woman, will illustrate the importance of developing art programs to combat the effects of systematic racism within Community Based Organizations. Arts as Resistance, will function as an educational, interactive, and intimate space, empowering participants to use art in their community mobilizing efforts. Amidst the demand of presence on social media platforms, art can also be used to implement strategic social network recruitment methods that is essential for HIV testing, linkage to care, and retention in HIV medical care.

Heather O’Connor, ICW-NA, Natural Bridge, VA

Breastfeeding (inclusive of chestfeeding) is generally considered the healthiest infant-feeding option but becomes more complex for parents living with HIV. While the standard of care in low-resource settings, breastfeeding among women with HIV is discouraged in the US, Canada, and other high-resource settings’ guidelines, resulting in limited research, provider-focused information, and clinical standards on breastfeeding and HIV in these areas. In December 2020, The Expert Consensus Statement on Breastfeeding and HIV in the United States and Canada called to advance efforts around infant feeding, including centering the experiences of women and other birthing parents living with HIV in the US and Canada. This session will describe the recommendations from this multidisciplinary, multi-sectoral group of experts, who identified and described

60

2021

UNITED STATES CONFERENCE ON HIV/AIDS

SESSION 4 WORKSHOPS

FRIDAY

DEC

3

Collaborative Language: the Intersection of HIV, Substance Use, and Incarceration

Providing Care along the Virtual Continuum of PrEP Care

Track: Prioritizing People Living with HIV Level: Intermediate Presenters:

Track: Best Practices in TeleHealth Level: Intermediate Presenters:

Adelaide Murray, MPH, JSI Research and Training Institute Inc., Bow, NH

Rupa Patel, MD, MPH, DTM&H, Washington University in St. Louis, St. Louis, MO

Devon Brown, LMSW MPH, JSI Research and Training Institute Inc., Atlanta, GA Juli Powers, MPH, JSI Research and Training Institute Inc., Atlanta, GA

In this interactive workshop, participants will develop skills and capacity to support people living with HIV that have concurrent needs within the United States HIV, substance use, and penal systems. Facilitators will frame the workshop through the lens of the vast and long-standing racial disparities that exist within and at the intersection of these three systems.

Session activities will focus on the need for respectful and shared language to improve care for individuals and reduce disparities across systems.

To effectively facilitate care coordination and promote positive health outcomes for people living with HIV, service providers, support staff, and advocates require a shared understanding and foundational agreement of tone, attitude, and approach to the work. Better coordination is needed to improve respectful and dignified access to resources and services across these systems for people living with HIV.

It’s About Time - HIV Research Just for Transgender Women Track: Treatment and Research Level: Beginner Presenters: Annet Davis, RN, MSW, CCRC, University of Pennsylvania, Philadelphia, PA Jonatan Gioia, MD, University of Texas Health Science Center, Houston, TX

Julia Lopez, PhD, MPH, LCSW, Washington University in St. Louis, St. Louis, MO Ashley Underwood, MPH, Washington University in St. Louis, St. Louis, MO Frederick Robinson, Minority Health Saint Louis, St. Louis, MO Jesus Villalobos, Washington University in St. Louis, St. Louis, MO

The PrEP care continuum, defined in 2017 by Nunn et al. has become an innovative way to assess effective PrEP interventions and has allowed for a better understanding of PrEP care. During this time of the COVID pandemic, telehealth has become an innovative tool that has allowed access to HIV prevention and care. Even as we move closer to returning to normal in-person activities, Telehealth will remain a crucial strategy for HIV prevention and care. Knowing how to adapt the PrEP care continuum for the virtual world is key to creating effective TelePrEP interventions.

Drawing from their own experiences, the speakers, who all have different service provision roles along the care continuum; will discuss challenges faced and lessons learned while adapting formerly in-person care to TelePrEP. This session will help attendees’ better grasp how to develop comprehensive Telehealth programs that encompass each step of the virtual PrEP care continuum.

End HIV 901: Achieving Health & Harmony in Memphis

Nora Howell, ICAP Harlem Prevention Center, Columbia University Medical Center, New York, NY

Track: Ending the HIV Epidemic (EHE) - Next Steps Level: Intermediate Presenter:

Byancha Lawson, University of Texas Health Science Center, Houston, TX

Eddie Wiley, MPH, Tennessee Department of Health, Memphis, TN

Rona Siskind, MHS, Division of AIDS, NIAID, Bethesda, MD

Memphis is one of 57 jurisdictions receiving Ending the HIV Epidemic (EHE) planning and implementation funding. Since October 2019, in partnership with Tennessee Department of Health (TDH), local EHE leaders broadened HIV community participation to establish diverse partnerships and increase public awareness of Memphis’ “End HIV 901” Plan.

Transgender women are disproportionately affected by HIV, yet HIV treatment and prevention research has only just begun to catch-up. Two clinical trials research networks funded by the National Institute of Allergy and Infectious Diseases (NIAID) are both planning studies designed exclusively for transgender women. One of the studies will focus on HIV treatment for transgender women living with HIV, while the other will evaluate an integrated strategies approach to HIV prevention among transgender women. This workshop will take a closer look at both of these studies, their design, the approaches used to gain community input and support, and the training that’s been undertaken to ensure cultural responsiveness among research staff. Resources that are available to support gender-inclusive HIV research will also be highlighted.

Although EHE funds were awarded to TDH, the state’s strategic EHE efforts include intentional community involvement, unique partnerships for innovation and heightened public awareness of each of the EHE pillars. How Memphis is “achieving health and harmony in the 901” (the primary area code for Memphis), the local EHE mission, will be described through an interactive workshop. Participants will get a chance to review the timeline of End HIV 901, discuss strategies to increase community involvement, examine effective data to action practices, promote innovation to achieve goals, share techniques to increase collaboration, and learn ways to promote EHE and related strategic plans.

#2021USCHA

61

DEC

3

FRIDAY

When the Party is over: A conversation about sex, chems, HIV and mental health Pathway: Gay Men Presenters:

SESSION 4 WORKSHOPS

40 Years of Resilience & Thriving Pathway: Aging Presenters: Tez Anderson

Alexi Díaz and Andrés Acosta, NMAC’s Gay Men of Color Fellows

Linda Scruggs

Sex, substance use, mental health, and HIV are all interconnected. Holistic approaches to sexual health must not only encompass physical aspects but also how the experiences of stigma impact mental health. Additionally, HIV and substance criminalization laws put a halt to speaking openly about these issues as they are both seen as a threat by the criminalization systems. In this workshop, Alexi Díaz and Andrés Acosta, will be sharing their perspectives on the intersections between chemsex, HIV, and criminalization. They will also engage with the audience as they provide solutions to overcome these barriers.

Moderator: Carole Treston

Moving forward, grantee lessons learned and valuable resources from SAMHSA

Pathway: Aging Presenters: Jeff Kwong DNP, RN, ANAC Moderator: Carole Treston, ANAC

Dr. Kirk James, SAMHSA Center for Substance Use Treatment, Rockville, MD Ms. Melissa de Jesús, SAMHSA Center for Substance Use Treatment, Rockville, MD Ms. Judith Ellis, SAMHSA Center for Substance Use Prevention, Rockville, MD Ms. Kristin Roha, SAMHSA Office of the Chief Medical Officer, Rockville, MD

Join Program Officials from the Substance Abuse and Mental Health Services Administration (SAMHSA) as they provide an overview of the latest trends from the National Survey on Drug Use and Health. Data measures and outcomes will be shared by several grant programs that are administered by SAMHSA which focus on providing behavioral health services to individuals experiencing Substance Use Disorders who may also be living with or at risk of HIV. This workshop will also highlight information presented in the recent publication of an Evidence-Based Resource Guide on Prevention and Treatment of HIV Among People Living with Substance Use and/or Mental Disorders available on the SAMHSA website. This interactive session will share perceived challenges in our field and an opportunity for attendees to share their experiences, including potential solutions to these challenges.

2021

Older Adults with HIV: Awareness and management of common co-occurring conditions

John Faragon. PharmD, ANAC

Pathway: SAMHSA Presenters:

62

This session features an engaging dialogue between two people living with HIV, both for more than 30 years. They describe their journeys in building resilience and supporting their emotional well-being and self-care, including practical tips to strengthen one’s resilience while aging with HIV.

UNITED STATES CONFERENCE ON HIV/AIDS

Presented by experienced HIV clinicians, a Nurse Practitioner and Pharmacist discuss common co-occurring conditions often associated with aging with HIV. Managing symptoms and medications with the goals of maintaining health and wellness and Q&A from the audience will be features of this session.

Calling for Change: Reports from the Convening on HIV and Employment Presented by FAPP Pathway: Structural Interventions

Growing out of rising awareness of social determinants of health and quality of life factors in HIV care and prevention contexts, the first National Convening on HIV and Employment brought together community advocates, policy experts, service providers, and researchers sharing stakeholder expertise and responsibilities. Members of the Convening Leadership Planning Team will share reports on the calls for change that emerged from the sessions conducted across its two afternoons, including recommendations for government agencies, community-based organizations, employers, and policymakers. Discussion will focus on a vision of not just what is, but what can be - to greatly reduce the lack of access to information, services, resources, and opportunities experienced across the most HIV-burdened regions and communities struggling with health, economic, and employment disparities.

Input provided by workshop attendees will inform the development and implementation of recommendations for strengthening responses to employment needs in HIV care and prevention.

FRIDAY

SESSION 2 INSTITUTES

DEC

3

4:00 PM - 5:30 PM EST Session 2 Institutes

This is Our Story: HIV Impact and Opportunities in the Rural South Presented by: Southern AIDS Coalition

LTS opportunities to engage, convene, and advocate for the unique needs of HIV/LTS. Objectives:

Moderators:

•

Demonstrate the power and importance of networks of PLWH

Marnina Miller, Justine Ingram and Gina Brown, Southern AIDS Coalition

•

Share with peers and hear from experts about other networks that currently exist

•

Provide a step-by-step plan on how to create your own local long-term survivor network

Presenters:Billy Willis (he/him/his), Youth Ambassador, Youth Across Borders, Elon, NC) Katie Willingham (she/her/hers), The Well Project, Tuscumbia, AL Tammy Kinney, (she/her/hers), Rural Women In Action Inc., Winder, GA Morgan Farrington, (they/them), GoodWorks: North AL Harm Reduction, Huntsville, AL Cedric Sturdevant (he/him/his), CH-PIER, Greenville, MS

This session will weave together stories and data to share the complexity of addressing the needs of southern rural communities. While the Deep South has consistently experienced the highest HIV burden for more than a decade, rural communities face additional layers of systemic inequities that make HIV prevention and care efforts even more challenging. The Deep South has the highest number of uninsured individuals, low PrEP uptake, and a demonstrated critical need for evidence-based and coordinated strategies to effectively address HIV (HIV in the US Deep South: Trends from 2008-2019). What specific actions are needed to improve conditions in rural southern communities?

Centered around storytelling, this institute will share communityled innovations and lessons learned in meeting the needs of rural communities in the fight to end the HIV epidemic. During this session, speakers will share various strategies used to combat HIV stigma, service deserts, and social isolation in the rural south.

The ABC’s of Building a Local Long-Term HIV Survivor Network

Sin voz, ni voto: The hidden victims of the intersection of Covid-19, Crystal Meth, and HIV in our Latino communities.

Presented by the Latinx CAP Carlos Rodríguez-Díaz, Associate Professor at George Washington University Britzeida Ramos Santiago, MSW, Director of Services, PACTA, Inc. – Arecibo, PR Richard Zaldivar, Executive Director & Founder, The Wall/Las Memorias Oscar López, CEO, Poderosos

This year’s Institute will focus on the disparities that still remain and continue arising in our communities, with particular emphasis on those that must remain hidden due to language barriers, immigration status, lack of access to adequate services (either because of location, transportation, or not being part of a priority group), stigma related to substance use and mental health, and lack of representation in decisionmaking bodies.

We aim to create a plan that responds to the question: “Where do we go from here?” by creating a plan identifying key strategies to address these disparities. We will be able to work on the plan through the year and reexamine it for progress and fine-tuning in future USCHA Latinx Institutes.

Presented by The Reunion Project

The Reunion Project (TRP) is the national alliance on HIV long-term survival in the United States. Today, TRP is the only national, community-based project using peer-led storytelling, information sharing and network development to connect long-term survivors of HIV (HIV/LTS) across the communities most affected HIV.

United We Rise: What would the response to HIV look like if it were led by Black people?

The Reunion Project will host a hands-on Institute for community leaders on how to create a TRP long-term survivor network/in your local community. The session will include both panel discussions and peersharing opportunities. The session will layout a blueprint and key steps to setting up a local long-term survivor network. These steps include planning, sponsorship, fundraising and identifying other HIV/LTS members. By creating a formal HIV/LTS network we will provide local HIV/

United We Rise is a national effort to Unite and Mobilize a collective force to end the HIV epidemic in our community and Uplift the Quality of Life of Black people. Addressing HIV within Black communities and improving our physical and mental health is defined by United We Rise as both internal and external processes, demanding that all segments of Black communities be heard and mobilized.

Presented by United We Rise

What would the response to HIV look like if it were led by Black people?

#2021USCHA

63

DEC

3

FRIDAY

This institute will engage participants in an interactive examination of the process by which United We Rise was developed and its evolution to a focus on liberation as an overarching public health strategy for Black people. We will explore how United We Rise reimagined a national convening, liberating it from traditional conference planning, themes, and format. Participants will then be engaged to examine the United We Rise: Every (Black)Body (UWR/EBB) Focus Areas: Black Community Engagement, Black Leadership & Organizations, Intersectionality, Sex & Sexual Identity, and Policy. They will view and discuss video excerpts from the ‘Couch Conversation” segments from the convening, as well as the Every(Black) Body Live! social media series. Local dissemination and replication of UWR/EBB strategies and assets will be discussed.

Keeping Our Circle Strong: Effective Collaborations for AI/AN Community Presented by the American Indian/ Alaska Native CAP Presenters: Chris Paisano, Coordinator for Indian Country, NMAC Rick Haverkate, Program Lead, National HIV/HCV Program, Indian Health Service Hannah Warren, Senior Program Manager, HIV/STD Prevention Program, Alaska Native Tribal Health Consortium Savannah Gene, Program Director, Community Health & Education & Resiliency Program, AAIHB Kurt Begaye, Capacity Building Specialist, Community Health & Education & Resiliency Program, AAIHB

This Institute will assist providers and constituency to better serve AIAN communities and to provide updates on national and regional HIV programming by Alaska Native Tribal Health Consortium, Indian Health Services, and NMAC. Participants will engage in discussions to assist with in identifying and developing strategic outcomes for the AIAN community.

Participants will also have the opportunity to network and strengthen collaborations with AIAN providers and agencies who serve AIAN.

64

2021

UNITED STATES CONFERENCE ON HIV/AIDS

SESSION 2 INSTITUTES

Advocate, Tell Your Story, Advocate!

Presented by National AIDS Housing Coalition and HUD Lauren Banks Killelea, Director of Policy & Advocacy, National AIDS Housing Coalition

The best way to ensure there is enough affordable housing for all people is to advocate for policies and programs. In this session you will learn a very basic overview of the federal budget process and the steps along the way where your advocacy is necessary. This session will include tips for how to advocate and tell your story of lived experience of homelessness or living with HIV/AIDS. We will have time for questions and dialogue so people can leave this session feeling ready to go talk to their members of Congress about housing as healthcare!

Asian Communities: Surviving the Colliding Pandemics Presented by the Asian CAP

This past year has been devastating to our Asian communities, not only in continuing our fight to end HIV/AIDS, but with colliding pandemics of COVID-19 and Asian Hate. Since the COVID-19 pandemic began in early 2020, a sharp rise in anti-Asian violence and hate speech has affected the Asian community across the U.S, partially driven by the blaming of the origin of COVID-19 from China, as well as long-standing antiasian discrimination. This institute will discuss how leadership assured access to ongoing HIV/AIDS services, implemented emergent strategies to protect PLWH during the COVID-19 pandemic and strategies to combat Asian Hate. Now is the time to come together as a united community, to nurture and heal from these colliding pandemics, and to recommit our efforts toward justice and equity.

CLOSING PLENARY

FRIDAY

DEC

3

5:45 PM - 6:45 PM EST Closing Plenary

Foundation Stones to Building the EHE Effort in Indian Country Presented by the American Indian/Alaska Native CAP

This plenary will highlight the work of those addressing HIV and COVID in Indian Country, ru-ral states, and among Alaska Natives with limited infrastructure. This plenary addresses these challenges and provides innovative solutions by Indian Country–making the case to support Na-tive HIV care by providing essential building blocks.

Speakers:

Platero

Hubbard

Haverkate

Paisano

Laura Platero, Northwest Portland Area Indian Health Board Annette Hubbard, Ninilchik Village Tribe Health & Community Department Rick Haverkate, Indian Health Service Christopher Paisano, NMAC

#2021USCHA

65

SESIONES PARA LA INTERPRETACION EN ESPAÑOL 2 DE DICIEMBRE Sesión 1: De 4:30 a 5:30 PM

Puerto Rico: Cómo crear una evaluación de necesidades para la comunidad transgénero Track: Track en español Nivel: Principiante Ponente: Arianna Lint, Arianna’s Center, Fort Lauderdale, FL

La comunidad transgénero de Puerto Rico sufre tasas desproporcionados de discriminación y falta de acceso a la atención de salud, vivienda y empleo en comparación con la población en general. La violencia contra los transexuales es también una realidad que la comunidad enfrenta a diario, a tal punto que el Gobernador ha declarado recientemente estado de emergencia en respuesta al número de asesinatos de alto perfil de personas transexuales ocurridos en los últimos 12 meses.

Para abordar estos problemas es esencial un mayor acceso a servicios sociales y un aumento de los recursos, incluidos fondos, pero la falta de datos suele crear obstáculos para conseguir este apoyo. En respuesta, el Centro Arianna, bajo la orientación de la Universidad de Puerto Rico, llevó a cabo una evaluación de las necesidades a gran escala de la comunidad transgénero en Puerto Rico en 2020 para comprender mejor los problemas que afectan a sus vidas. Este estudio contó con la colaboración de más de 300 personas de todo Puerto Rico, representabando una sección transversal diversa de la comunidad.

3 DE DICIEMBRE Sesión 2: De 11:00 a 12:00 PM

Fortalecimiento institucional para proveedores Latinx en los tiempos del COVID-19 Track: Track en español Level: Intermediate Presenter(s): Miguel Chion, MD, MPH, CAI, Los Angeles, California Arismendi Jimenez, MD, CAI, New York, New York Erika Roca, MPH, CAI Los Angeles, California

66

2021

UNITED STATES CONFERENCE ON HIV/AIDS

Ponerle fin a la epidemia del VIH en los EEUU requiere un esfuerzo concertado, sostenido y equitativo. Históricamente, las organizaciones que sirven a la población latina reportan dificultades de acceso a experiencias de fortalecimiento institucional. La pandemia del COVID 19, contribuye y potencia dichas barreras. ¿Cómo podemos lidiar con estas barreras?

Durante esta sesión CAI presentará su experiencia de proveer fortalecimiento institucional a pesar de la pandemia del COVID 19.

Durante este taller se revisará las limitaciones que los proveedores de servicios VIH a la población latina enfrentan: el acceso a cursos en español, la falta de materiales culturalmente apropiados, el efecto del COVID 19 y el pobre acceso a tecnología necesaria para los cursos remotos. CAI presentará un marco conceptual (matriz) de cómo se están enfrentando dichas barreras, el portafolio de cursos en español, así como también los resultados y lecciones aprendidas de esta experiencia.

Sesión 3: De 1:15 a 2:15 PM

Respuesta Comunitaria al COVID-19 en Latinx en los Estados Unidos Track: Track en español Level: Intermediate Presenter: Pedro Goicochea, Legacy Project | Office of HIV/AIDS Network Coordination - HANC, Seattle, WA

El Latinx Caucus, un grupo de trabajo de Legacy Project de la Office of HIV/ AIDS Network Coordination (HANC), tiene como finalidad crear conciencia e incrementar la representatividad y participación de latinas y latinos en la investigación clínica en VIH, ITS, TB y COVID-19.

La comunidad latina en los Estados Unidos es la segunda comunidad más afectada por la epidemia del COVID-19. De todos los casos de COVID-19 reportados, 28.8% corresponden a este grupo, después de los blancos, 50% (CDC, 6-21-2021). Asimismo, las tasas de vacunación en esta comunidad continúan siendo bajos (15%), pero mejorando; en los últimos 14 días, 3/10 vacunas fueron administradas a latinos y latinas (KFF, 6-162021).

Este taller interactivo busca generar un espacio de discusión acerca del impacto de la epidemia del COVID-19 en la comunidad latina; identificar los factores que contribuyen a esta situación y proponer alternativas

SESIONES PARA LA INTERPRETACION EN ESPAÑOL Sesión Sesión44: De 2:30 a 3:30 PM

¿PrEParadx para el futuro?: Métodos innovadores para prevenir el VIH Track: Track en español Level: Intermediate Presenter: Jonatan Gioia, MD, University of Texas Health Science Center at Houston, Houston, TX

¿Te imaginas un mundo en donde puedas elegir entre un inyectable, un implante o una pastilla como PrEP? Nuevas y excitantes estrategias y medicamentos se están desarrollando para ampliar nuestra caja de herramientas para prevenir el VIH. Es importante involucrar a nuestras comunidades para que aprendan sobre estos nuevos avances científicos.

En este taller interactivo, los participantes obtendrán información científica básica sobre nuevos medicamentos y estrategias para prevenir el VIH. Los participantes serán invitados a pensar en las futuras barreras para la implementación de estas estrategias como así también posibles soluciones para las mismas. Únete a la conversación. ¿Estas preparadx para el futuro?

Sesión del Instituto: De 4:00 a 5:30 PM

Sin voz, ni voto: Las víctimas ocultas de la intersección de Covid-19, Crystal Meth y el VIH en nuestras comunidades latinas.

Presentado por el CAP Latinx Carlos Rodríguez-Díaz, profesor asociado de la Universidad George Washington Britzeida Ramos Santiago, MSW, Directora de Servicios, PACTA, Inc. Arecibo, PR Richard Zaldivar, Director Ejecutivo & Fundador, The Wall/Las Memorias Oscar López, director general de Poderosos

El Instituto de este año se centrará en las disparidades que siguen existiendo y continúan surgiendo en nuestras comunidades, enfocándonos en particular en aquellas que no son invisibles debido a las barreras lingüísticas, el estatus migratorio, la falta de acceso a servicios adecuados (ya sea por la ubicación, el transporte o por no formar parte de un grupo prioritario), el estigma relacionado con el consumo de sustancias y la salud mental, y la falta de representación en los órganos de decisión.

Nuestro objetivo es crear un plan que responda a la pregunta: “¿A dónde vamos desde aquí?” mediante la creación de un plan que identifique las estrategias clave para enfrentar estas disparidades. Podremos trabajar en el plan a lo largo del año y volver a examinarlo para comprobar el progreso y ajustarlo en futuros Institutos Latinx de la USCHA.

#2021USCHA

67

US Conference on HIV AIDS

B L OC

Ending Stigma through Collaboration And Lifting All To Empowerment

biomedical HIV prevention

summit At NMAC, we not only build leaders for the future...we build family.

nmac.org

BUILDING LEADERS OF COLOR

biomedical HIV prevention

summit

April 20-21 Chicago, IL www.biomedicalhivsummit.org #2022BHPS

OCT10-13, 8-11, 2022 OCT 2020 SanJuan, Juan, PR San

PuertoRico Rico Puerto Convention Center Center Convention

SPONSOR PROSPECTUS

US Conference on HIV AIDS

#2020uscha #2022uscha uscha.life uscha.life

www.nmac.org NMACCommunity NMACCommunity commnmac NMACHIV